Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 46(2); 2014 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011
Kyu-Won Jung, MS1,2, Young-Joo Won, PhD1,2, Hyun-Joo Kong, MS1,2, Chang-Mo Oh, MD, PhD1,2, Duk Hyoung Lee, MD, PhD2, Jin Soo Lee, MD, PhD1
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2014;46(2):109-123.
DOI: https://doi.org/10.4143/crt.2014.46.2.109
Published online: April 15, 2014

1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea.

2National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Correspondence: Young-Joo Won, PhD. The Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea.
Tel: 82-31-920-2015, Fax: 82-31-920-2179, astra67@ncc.re.kr
• Received: March 9, 2014   • Accepted: March 18, 2014

Copyright © 2014 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 24,498 Views
  • 190 Download
  • 281 Web of Science
  • 301 Crossref
  • 270 Scopus
next
  • Purpose
    This study aimed to report nationwide cancer statistics in Korea, including incidence, mortality, survival, and prevalence, and their trends.
  • Materials and Methods
    Incidence data from 1993 to 2011 were obtained from the Korea National Cancer Incidence Database, and vital status was followed through December 31, 2012. Mortality data from 1983 to 2011 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, and prevalence, and relative survival were calculated.
  • Results
    A total of 218,017 cancer cases and 71,579 cancer deaths were reported to have occurred in 2011, and there were 1,097,253 prevalent cases identified in Korea as of January 1, 2012. Over the past 13 years (1999-2011), overall incidence rates have increased by 3.4% per year. The incidence rates of liver and cervical cancers have decreased, while those of thyroid, breast, prostate, and colorectal cancers have increased. Notably, thyroid cancer increased by 23.3% per year in both sexes, and became the most common cancer since 2009. The mortality for all cancers combined decreased by 2.7% per year from 2002 to 2011. Five-year relative survival rates of patients diagnosed in the last 5 years (2007-2011) have improved by 25.1% compared with those from 1993 to 1995.
  • Conclusion
    Overall cancer mortality rates have declined since 2002 in Korea, while incidence has increased rapidly and survival has improved.
Cancer has been the leading cause of death in Korea since 1983 [1] and is the most burdensome disease [2]. More than 200,000 new cancer cases are diagnosed in Korea each year, and cancer is responsible for one in four total deaths [3]. This article reports the most recent nationwide cancer statistics in Korea, including incidence, mortality, survival, prevalence, and their trends.
1. Data sources
The Ministry of Health and Welfare, Korea, initiated a nationwide hospital-based cancer registry called the Korea Central Cancer Registry (KCCR) in 1980. The registry collected 80-90% of cancer cases annually from more than 180 training hospitals throughout the country. In 1999, the KCCR expanded cancer registration to cover the entire population under the Population-Based Regional Cancer Registry program. Details of the history, objectives, and activities of the KCCR have been documented elsewhere [4]. Incidence data for 1999-2011 were obtained from the Korea National Cancer Incidence Database (KNCI DB). The completeness of incidence data for 2011 was 97.1%, as determined by the Ajiki method [5].
Cancer cases were classified according to the International Classification of Diseases for Oncology, 3rd edition [6] and converted according to the International Classification of Diseases, 10th edition (ICD-10) [7]. The survival analysis used 2,197,413 cancer cases first diagnosed between 1993 and 2011 from the KNCI DB, and followed vital status until December 31, 2012.
Mortality data from 1983 to 2011 were obtained from Statistics Korea [1]. Cause of death was coded and classified according to ICD-10 [7]. Population data were also obtained from Statistics Korea using the resident registration population on July 1 of specified years.
2. Analysis
Crude rates (CRs) and age-specific rates of cancer incidence and mortality were calculated. Age-standardized rates (ASRs) were calculated using Segi's world standard population [8]. Cumulative risks of cancer, which represent the probability of developing cancer during one's lifetime, were also calculated. Changes in the annual ASRs of cancer incidence were examined by calculating the annual percentage change over a time period as (exp(b)-1)×100, where b is the slope of the regression of log ASR for a given calendar year [9].
Prevalence was also calculated to assess cancer burden, which includes new and pre-existing cancer patients diagnosed during a given time period still alive on an index date. Using cancer incidence database data from 1999 to 2011, we defined prevalent cases as patients who were diagnosed between January 1, 1999 and December 31, 2011, and still alive on January 1, 2012. We calculated limited-duration prevalences, namely, 1- and 5-year prevalences. For example, the 5-year prevalence was calculated as the number of people alive on January 1, 2012 who had been diagnosed with cancer within the previous 5 years. We applied this counting method using the SEER*Stat software [10] to calculate the number of cases while adjusting for patients lost to follow-up.
The survival duration for each case was determined as the interval between the date of initial diagnosis and the date of death, date of loss to follow-up, or closing date for follow-up. Observed survival rates were calculated using the life-table method and relative survival rates with the Ederer II method [11] were based on an algorithm written in SAS by Paul Dickman [12], with some minor modifications.
1. Incidence
The overall number of incident cancer cases, deaths, and prevalent cases by sex and cancer site for 2011 in Korea are shown in Table 1. A total of 218,017 incident cancer cases and 71,579 deaths were reported to occur in 2011. As of January 1, 2012, 1,097,253 prevalent cancer cases diagnosed between 1999 and 2011 were identified. The cumulative risk of developing cancer during one's lifetime in 2011 was 38.1% for males and 33.8% for females.
The cancer incidence rates in 2011 by sex and cancer site are shown in Table 2. The 2011 CRs per 100,000 of all sites combined were 439.2 and 431.0 for males and females, respectively. The ASRs per 100,000 of all sites combined were 332.9 and 286.2 for males and females, respectively. In males, the five leading primary cancer sites were stomach (CR, 85.1; ASR, 63.3), colon and rectum (CR, 68.4; ASR, 51.4), lung (CR, 60.5; ASR, 46.0), liver (CR, 48.6; ASR, 35.6), and prostate (CR, 35.7; ASR, 27.4), which together accounted for 67.9% of all newly diagnosed cancers in 2011. In females, the most common cancer site was thyroid (CR, 134.1; ASR, 96.8), followed by breast (CR, 63.7; ASR, 43.8), colon and rectum (CR, 43.8; ASR, 26.4), stomach (CR, 41.1; ASR, 25.1), and lung (CR, 26.3; ASR, 15.1), which together accounted for 71.7% of all newly diagnosed cancers. Thyroid cancer alone accounted for 31.1% of incident cases (n=33,562) among females in 2011.
2. Mortality
A total of 71,579 cancer deaths were reported in Korea for 2011, accounting for 27.8% of all deaths (Table 3). In 2011, the CRs per 100,000 for all sites combined were 178.9 and 106.7 in males and females, respectively. The ASRs per 100,000 for all sites combined were 137.3 and 59.1 for males and females, respectively. Cancers of the lung, liver, stomach, and colon/rectum were the main leading causes of cancer death, together accounting for approximately 61.7% of all cancer deaths in 2011 (Table 4).
In males, the five most common sites of cancer death in 2011 were lung (CR, 45.9; ASR, 35.0), liver (CR, 32.8; ASR, 24.3), stomach (CR, 25.2; ASR, 19.3), colon and rectum (CR, 17.3; ASR, 13.4), and pancreas (CR, 9.5; ASR, 7.3). In women, lung cancer (CR, 17.4; ASR, 9.1) was the leading cause of cancer death in 2011, followed by stomach (CR, 13.6; ASR, 7.1), colon and rectum (CR, 13.2; ASR, 6.9), liver (CR, 10.9; ASR, 6.1), and breast (CR, 8.0; ASR, 5.2).
3. Trends in cancer incidence
The cancer incidence rates from 1999 to 2011 in Korea for all sites combined and for selected sites are shown in Tables 5,6,7. The incidence for all sites combined increased by 3.4% per year (1.6% in males, 5.4% in females) from 1999 to 2011. The rapid increase in cancer incidence is also illustrated in Fig. 1.
The incidence rates for colorectal and thyroid cancers have continued to increase in both sexes, as have those for prostate cancer in males and breast cancer in females (Fig. 2). In contrast, the incidences of liver cancer in both sexes, lung cancer in males, and cervical cancer in females have decreased. Notably, thyroid cancer increased by 23.3% per year rapidly in both sexes, and became the most common cancer since 2009. Improvements in the sensitivity of diagnostic techniques for thyroid cancer, such as the advent of ultrasound and fine-needle aspiration, have enabled the detection of small-sized thyroid cancers. Furthermore, screening rates have increased. Therefore, the increased incidence of thyroid cancer might reflect the identification of previously undetected diseases rather than a true increase in the occurrence of thyroid cancer [13,14,15,16]. Furthermore, due to the construction of a 1999-2011 KNCI DB, the completeness of the Korean cancer registry data has improved gradually, and this may have contributed, in part, to the gradual overall increases in cancer incidence, particularly among elderly patients.
4. Age-specific incidence rates
The most common cancer sites by sex and age group in 2011 are shown in Table 8. Leukemia and thyroid cancer were the most common cancer in both sexes in patients aged 0-14 and 15-34 years, respectively. For males, stomach cancer was the most common cancer in those aged 35-64, while lung cancer was more frequent among patients aged 65 and over. Thyroid cancer was the most common cancer in females aged 35-64 years, and colorectal cancer was the most common cancer among older females aged 65 and over.
The age-specific incidence rates for selected cancers in males and females in 2011 are shown in Fig. 3. The graphs show that the incidences of stomach, lung, liver, and colorectal cancers increased gradually with age. Incidences of breast and thyroid cancers in females were highest among patients in their late 40s and early 50s, respectively, and leveled off thereafter. The age-specific pattern of breast cancer is different from those in Western countries [17].
5. Trends in cancer mortality
The trends in cancer deaths for all sites combined and for selected sites are shown in Figs. 1 and 4. ASRs of mortality for all sites combined decreased 2.7% per year in both sexes since 2002. Lung cancer surpassed stomach cancer as the leading cause of cancer death in 1999 and is expected to account for 22.2% of all cancer deaths in 2011. However, the ASRs of mortality due to lung cancer have decreased slightly in both males and females since 2002. The ASRs of mortality due to stomach and uterus cancers also have decreased continuously. Along with significant increases in colorectal, prostate, and female breast cancer incidence rates, mortality rates of these cancers have also continued to increase.
6. Survival rates
The trends in relative survival for all sites combined among both sexes by year of diagnosis from 1999 to 2011 are shown in Fig. 5. The relative survival for all sites combined increased with year of diagnosis, and also increased when we excluded thyroid cancer cases in our analysis.
Table 9 shows the 5-year relative survival rates for four diagnosis periods: 1993-1995, 1996-2000, 2001-2005, and 2007-2011. Patients who were diagnosed with cancer in the most recent period (2007-2011) had a 5-year relative survival rate of 66.3% for all sites combined in both sexes (57.6% in males and 75.2% in females). When compared with earlier periods, notable improvements in the 5-year relative survival rates were observed for all sites combined. The higher cancer survival rate in females might be partly explained by cancers common in females (e.g., thyroid, breast, and cervix uteri cancers) having relatively good prognoses.
When examined by year of diagnosis and cancer site, the 5-year relative survival rates appeared to be higher for most major cancers in patients diagnosed from 2007 to 2011 compared with those diagnosed from 1993 to 1995, with the exception of pancreatic cancer. The greatest improvements were seen in cancers of the prostate, stomach, leukemia, lip/oral cavity/pharynx, and non-Hodgkin lymphoma. The improving survival rates could be attributable to early detection and improved treatments [18,19], but this requires further evaluation. Only pancreatic cancer showed no improvement in 5-year relative survival rate compared with 1993-1995. A lack of progress in early detection and treatment could explain the observed absence of improvement in the survival rate for pancreatic cancer [20].
7. Prevalence rates
The cancer prevalence rates by sex and cancer site on January 1, 2012 in Korea are shown in Table 10. The CRs per 100,000 of cancer prevalence for all sites combined were 1,959.6 and 2,420.1 in males and females, respectively, and the ASRs per 100,000 of cancer prevalence for all sites combined were 1,488.7 and 1,618.5 in males and females, respectively. In males, the five leading primary sites of cancer for prevalence were stomach (CR, 500.5; ASR, 372.7), colon and rectum (CR, 367.7; ASR, 276.4), prostate (CR, 168.1; ASR, 129.0), liver (CR, 142.3; ASR, 105.6), and thyroid (CR, 132.0; ASR, 94.7), which together accounted for 66.9% of all prevalent cancer cases. In females, the most common cancer site was thyroid (CR, 727.4; ASR, 512.0), followed by breast (CR, 468.0; ASR, 316.3), stomach (CR, 253.6; ASR, 154.9), colon and rectum (CR, 250.0; ASR, 150.7), and cervix uteri (CR, 164.1; ASR, 108.4), which together accounted for 77.0% of all prevalent cancer cases.
The prevalence by time since diagnosis is shown in Fig. 6. For all cancers combined, the 2-year prevalence constituted 31.4% of all prevalent cases. The 2-year prevalence, as a percentage of the total prevalence, was highest for thyroid (22.2%), followed by stomach (15.0%) and colon and rectum (13.8%), which had high incidence rates and good prognoses. For all cancers combined in both sexes, the 2-5-year and >5-year prevalences accounted for 31.1% and 37.6% of the total prevalence, respectively. The long-term prevalences for lung and liver cancers were relatively low due to low survival rates of lung cancer patients.
Acknowledgements
This work was supported by a research grant from the National Cancer Center (No. 1310220), Republic of Korea. The authors are indebted to Korea Central Cancer Registry (KCCR)-affiliated hospitals, non-KCCR-affiliated hospitals, 11 regional cancer registries (the Busan, Daegu & Gyeongbuk, Gwangju & Jeonnam, Incheon, Daejeon & Chungnam, Ulsan, Gangwon, Chungbuk, Jeonbuk, Gyeongnam and Jejudo cancer registries), the National Health Insurance Service and Statistics Korea for data collection.

Conflict of interest relevant to this article was not reported.

  • 1. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2014. cited 2014 Jan 4Available from: http://kosis.kr
  • 2. Yoon SJ, Bae SC, Lee SI, Chang H, Jo HS, Sung JH, et al. Measuring the burden of disease in Korea. J Korean Med Sci. 2007;22:518–523. PMID: 17596664ArticlePubMedPMC
  • 3. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat. 2013;45:1–14. PMID: 23613665ArticlePubMedPMCPDF
  • 4. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–331. PMID: 19956367ArticlePubMedPMCPDF
  • 5. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–1017. PMID: 9893469PubMed
  • 6. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
  • 7. World Health OrganizationInternational statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
  • 8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  • 9. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al. SEER cancer statistics review, 1975-2010. Bethesda: National Cancer Institute; 2013.
  • 10. National Cancer InstituteSEER*Stat Program, version 6.6.1 [Internet]. Bethesda: National Cancer Institute; 2013. cited 2013 Jan 4Available from: http://seer.cancer.gov/seerstat/
  • 11. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note. No. 10. Bethesda: National Cancer Institute; 1959.
  • 12. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2014. cited 2014 Jan 14Available from: http://www.pauldickman.com
  • 13. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–2167. PMID: 16684987ArticlePubMed
  • 14. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18:784–791. PMID: 19240234ArticlePubMedPMC
  • 15. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011;12:1657–1663. PMID: 22126540PubMed
  • 16. Kim SY. Study to provide evidence of health screening service for thyroid cancer. Seoul: National Evidence-based Healthcare Collaborating Agency; 2012.
  • 17. Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, et al. Cancer incidence in five continents. Vol. 10 (electronic version). Lyon: IARC Press; 2013.
  • 18. Jung KW, Yim SH, Kong HJ, Hwang SY, Won YJ, Lee JK, et al. Cancer survival in Korea 1993-2002: a population-based study. J Korean Med Sci. 2007;22(Suppl):S5–S10. PMID: 17923755ArticlePubMedPMC
  • 19. Gondos A, Bray F, Hakulinen T, Brenner H. EUNICE Survival Working GroupTrends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009;20:564–573. PMID: 19066327ArticlePubMed
  • 20. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260:103–117. PMID: 16882274ArticlePubMed
Fig. 1
Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2011 in Korea. Age standardization was based on the world standard population.
crt-46-109-g001.jpg
Fig. 2
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2011 in Korea. Age standardization was based on the world standard population. (A) Male. (B) Female.
crt-46-109-g002.jpg
Fig. 3
Age-specific incidence rates of major cancers for 2011 in Korea. (A) Male. (B) Female.
crt-46-109-g003.jpg
Fig. 4
Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2011 in Korea. Age standardization was based on the world standard population. (A) Male. (B) Female.
crt-46-109-g004.jpg
Fig. 5
Trends in relative survival by year of diagnosis from 1999 to 2011. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
crt-46-109-g005.jpg
Fig. 6
Prevalence of major cancer sites by time since diagnosis on January 1, 2012 in Korea.
crt-46-109-g006.jpg
Table 1
2011 Cancer incidence, prevalence, and deaths by sex in Korea
Site/Type New cases Deaths Prevalent casesa)



Both Male Female Both Male Female Both Male Female
All sites 218,017 110,151 107,866 71,579 44,860 26,719 1,097,253 491,505 605,748
Lip, oral cavity, and pharynx 2,876 2,102 774 940 727 213 15,525 10,517 5,008
Esophagus 2,245 2,053 192 1,507 1,368 139 6,813 6,157 656
Stomach 31,637 21,344 10,293 9,719 6,321 3,398 188,995 125,526 63,469
Colon and rectum 28,112 17,157 10,955 7,660 4,351 3,309 154,816 92,236 62,580
Liver 16,463 12,189 4,274 10,946 8,226 2,720 47,698 35,689 12,009
Gallbladderb) 4,993 2,479 2,514 3,701 1,825 1,876 13,531 6,895 6,636
Pancreas 5,080 2,807 2,273 4,379 2,394 1,985 6,379 3,504 2,875
Larynx 1,108 1,042 66 387 354 33 8,143 7,651 492
Lung 21,753 15,167 6,586 15,867 11,503 4,364 48,795 31,857 16,938
Breast 16,015 73 15,942 2,018 19 1,999 117,652 523 117,129
Cervix uteri 3,728 - 3,728 989 - 989 41,077 - 41,077
Corpus uteri 1,921 - 1,921 217 - 217 13,563 - 13,563
Ovary 2,010 - 2,010 901 - 901 12,918 - 12,918
Prostate 8,952 8,952 - 1,403 1,403 0 42,157 42,157 -
Testis 226 226 - 20 20 0 1,979 1,979 -
Kidney 3,989 2,722 1,267 834 583 251 23,076 15,549 7,527
Bladder 3,549 2,847 702 1,169 853 316 23,779 19,358 4,421
Brain and CNS 1,592 847 745 1,214 663 551 8,013 4,160 3,853
Thyroid 40,568 7,006 33,562 389 116 273 215,178 33,112 182,066
Hodgkin lymphoma 259 163 96 49 36 13 1,812 1,154 658
Non-Hodgkin lymphoma 4,367 2,396 1,971 1,389 809 580 23,627 12,837 10,790
Multiple myeloma 1,050 589 461 661 357 304 3,431 1,842 1,589
Leukemia 2,862 1,598 1,264 1,557 904 653 13,672 7,527 6,145
Other and ill-defined 12,662 6,392 6,270 3,663 2,028 1,635 64,624 31,275 33,349

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2012. These are patients who were diagnosed between January 1, 1999 and December 31, 2011 and who were alive on January 1, 2012. Multiple primary cancer cases were counted multiple times,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 2
Crude and age-standardized cancer incidence rates by sex in Korea, 2011
Site/Type Crude incidence rate per 100,000 Age-standardized incidence rate per 100,000a)


Both Male Female Both Male Female
All sites 435.1 439.2 431.0 299.8 332.9 286.2
Lip, oral cavity, and pharynx 5.7 8.4 3.1 4.0 6.3 2.1
Esophagus 4.5 8.2 0.8 3.0 6.2 0.4
Stomach 63.1 85.1 41.1 42.5 63.3 25.1
Colon and rectum 56.1 68.4 43.8 37.8 51.4 26.4
Liver 32.9 48.6 17.1 22.2 35.6 10.3
Gallbladderb) 10.0 9.9 10.0 6.4 7.6 5.5
Pancreas 10.1 11.2 9.1 6.6 8.5 5.1
Larynx 2.2 4.2 0.3 1.5 3.1 0.2
Lung 43.4 60.5 26.3 28.3 46.0 15.1
Breast 32.0 0.3 63.7 22.2 0.2 43.8
Cervix uteri 7.4 - 14.9 5.2 - 10.1
Corpus uteri 3.8 - 7.7 2.7 - 5.3
Ovary 4.0 - 8.0 2.9 - 5.7
Prostate 17.9 35.7 - 11.8 27.4 -
Testis 0.5 0.9 - 0.5 0.9 -
Kidney 8.0 10.9 5.1 5.6 8.1 3.4
Bladder 7.1 11.4 2.8 4.6 8.7 1.5
Brain and CNS 3.2 3.4 3.0 2.7 3.0 2.4
Thyroid 81.0 27.9 134.1 58.3 20.2 96.8
Hodgkin lymphoma 0.5 0.6 0.4 0.5 0.6 0.4
Non-Hodgkin lymphoma 8.7 9.6 7.9 6.5 7.7 5.5
Multiple myeloma 2.1 2.3 1.8 1.4 1.8 1.1
Leukemia 5.7 6.4 5.1 5.2 6.1 4.5
Other and ill-defined 25.3 25.5 25.1 17.8 20.3 15.7

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 3
The top 10 leading causes of death in Korea for 2011
Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
All causes 257,396 100.0 331.9
1 Cancer 71,579 27.8 91.8
2 Cerebrovascular disease 25,404 9.9 30.3
3 Heart disease 24,944 9.7 30.5
4 Intentional self-harm (suicide) 15,906 6.2 23.4
5 Diabetes mellitus 10,775 4.2 13.0
6 Pneumonia 8,606 3.3 10.2
7 Chronic lower respiratory diseases 6,959 2.7 8.0
8 Disease of liver 6,751 2.6 9.0
9 Transport accidents 6,316 2.5 9.7
10 Hypertensive diseases 5,038 2.0 5.9
Others 75,118 29.2 99.9

Source: Mortality data, 2011, Statistics Korea [1].

a) Age-adjusted using the world standard population.

Table 4
Crude and age-standardized cancer mortality rates by sex in Korea, 2011
Site/Type Crude mortality rate per 100,000 Age-standardized mortality rate per 100,000a)


Both Male Female Both Male Female
All sites 142.8 178.9 106.7 91.8 137.3 59.1
Lip, oral cavity, and pharynx 1.9 2.9 0.9 1.2 2.2 0.5
Esophagus 3.0 5.5 0.6 1.9 4.1 0.3
Stomach 19.4 25.2 13.6 12.3 19.3 7.1
Colon and rectum 15.3 17.3 13.2 9.6 13.4 6.9
Liver 21.8 32.8 10.9 14.5 24.3 6.1
Gallbladderb) 7.4 7.3 7.5 4.6 5.7 3.8
Pancreas 8.7 9.5 7.9 5.6 7.3 4.2
Larynx 0.8 1.4 0.1 0.5 1.1 0.1
Lung 31.7 45.9 17.4 19.8 35.0 9.1
Breast 4.0 0.1 8.0 2.7 0.1 5.2
Cervix uteri 2.0 - 4.0 1.3 - 2.3
Corpus uteri 0.4 - 0.9 0.3 - 0.6
Ovary 1.8 - 3.6 1.2 - 2.2
Prostate 2.8 5.6 - 1.6 4.6 -
Testis 0.0 0.1 - 0.0 0.1 --
Kidney 1.7 2.3 1.0 1.1 1.8 0.5
Bladder 2.3 3.4 1.3 1.4 2.7 0.6
Brain and CNS 2.4 2.6 2.2 1.8 2.2 1.5
Thyroid 0.8 0.5 1.1 0.5 0.4 0.5
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 2.8 3.2 2.3 1.8 2.5 1.3
Multiple myeloma 1.3 1.4 1.2 0.9 1.1 0.7
Leukemia 3.1 3.6 2.6 2.4 3.0 1.8
Other and ill-defined 7.3 8.1 6.5 4.8 6.3 3.7

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 5
Trends in cancer incidence rates for both sexes from 1999 to 2011 in Korea
Site/Type Year APC

1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
All sites 210.5 205.1 216.7 220.1 227.6 234.8 247.7 251.8 262.9 275.2 285.9 291.5 299.8 3.4a)
Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.8 3.9 4.0 0.4
Esophagus 4.1 3.7 3.9 3.8 3.6 3.6 3.5 3.4 3.3 3.3 3.1 3.1 3.0 ‒2.2a)
Stomach 43.6 42.3 44.0 43.6 43.2 41.2 44.4 42.8 41.8 42.5 43.3 42.3 42.5 ‒0.2
Colon and rectum 20.4 21.0 22.9 24.7 26.8 28.6 30.9 32.4 33.7 34.8 36.8 36.7 37.8 5.6a)
Liver 27.9 26.7 27.3 26.5 25.7 25.6 25.8 24.6 24.4 24.0 23.5 22.7 22.2 ‒1.8a)
Gallbladderb) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.6 6.4 6.8 6.6 6.4 ‒0.1
Pancreas 5.6 5.5 5.5 5.8 5.9 6.0 6.3 6.2 6.3 6.4 6.3 6.4 6.6 -1.5a)
Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.7 1.7 1.6 1.5 ‒3.6a)
Lung 28.5 27.7 28.3 28.5 27.9 28.8 29.0 28.7 28.4 28.2 28.2 28.4 28.3 0.0
Breast 10.7 10.8 12.7 13.9 14.2 15.0 16.3 16.9 18.1 18.9 19.6 20.5 22.2 6.1a)
Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.7 5.9 5.5 5.6 5.2 ‒4.2a)
Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 2.4 2.6 2.6 2.7 5.9a)
Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.1 2.9 2.8 3.0 2.9 1.3a)
Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.3 8.6 9.8 10.6 11.0 11.8 13.8a)
Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 4.3a)
Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.0 5.2 5.3 5.6 6.0a)
Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.6 4.6 4.6 ‒0.2
Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.0 3.0 3.0 2.7 0.5
Thyroid 6.3 6.1 7.9 9.5 12.8 17.2 20.7 25.4 32.8 41.3 48.0 53.5 58.3 23.3a)
Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.5 4.9a)
Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 4.9 5.3 5.3 5.5 5.6 5.6 6.1 6.1 6.5 3.5a)
Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 1.5 1.4 3.6a)
Leukemia 4.7 4.3 4.7 4.8 4.8 4.8 4.7 4.9 4.8 5.0 5.1 5.0 5.2 1.1a)
Other and ill-defined 14.3 13.5 13.9 13.5 15.2 15.2 16.2 16.1 17.1 17.0 17.0 17.3 17.8 2.4a)

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p<0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 6
Trends in cancer incidence rates in males from 1999 to 2011 in Korea
Site/Type Year APC

1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
All sites 285.0 276.7 288.3 290.0 294.8 299.4 311.3 310.0 316.4 323.3 329.8 329.7 332.9 1.6a)
Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.2 6.1 6.1 6.3 6.5 6.1 6.1 6.3 0.3
Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 7.0 7.0 6.6 6.5 6.2 ‒2.6a)
Stomach 66.2 65.0 67.2 66.6 65.9 62.3 66.9 65.4 63.1 64.4 64.9 63.1 63.3 ‒0.4a)
Colon and rectum 26.2 27.2 29.6 32.9 35.3 37.9 41.1 43.3 45.3 46.9 49.8 49.7 51.4 6.1a)
Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.2 39.7 39.4 38.1 36.7 35.6 ‒2.1a)
Gallbladderb) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.1 8.2 7.6 ‒0.2
Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.4 8.1 8.0 8.5 0.7a)
Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.8 3.8 3.5 3.6 3.4 3.1 ‒3.7a)
Lung 51.4 49.8 51.1 51.0 50.0 50.8 50.9 49.2 48.7 47.6 47.4 47.2 46.0 ‒0.8a)
Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 ‒0.9
Prostate 8.4 7.2 9.5 10.1 12.4 15.1 15.7 17.9 20.9 23.4 25.1 25.9 27.4 12.3a)
Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 4.2a)
Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.1 7.4 7.6 7.9 8.1 5.7a)
Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.4 9.1 8.7 8.8 8.7 ‒0.4
Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.1 3.4 3.4 3.4 3.4 3.0 0.6
Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.3 15.6 18.5 20.2 24.2a)
Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.6 0.6 3.9a)
Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.5 6.9 7.0 6.8 7.4 7.3 7.7 2.7a)
Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.5 1.6 1.7 1.9 1.8 1.8 3.3a)
Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.6 5.6 5.7 5.8 5.9 6.0 6.1 1.1a)
Other and ill-defined 17.9 16.5 16.8 16.5 18.5 18.2 19.2 18.8 20.2 19.7 19.9 19.6 20.3 1.7a)

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p<0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 7
Trends in cancer incidence rates in females from 1999 to 2011 in Korea
Site/Type Year APC

1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
All sites 61.1 157.4 169.0 174.6 184.3 193.4 207.8 16.4 232.0 249.0 263.0 273.6 286.2 5.4a)
Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 2.2 2.1 1.2
Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 0.4 0.4 ‒2.6a)
Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.1 24.8 25.1 25.7 25.2 25.1 ‒0.4
Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.5 23.0 24.1 24.5 25.1 26.3 26.0 26.4 4.5a)
Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.4 11.1 11.1 10.7 10.6 10.3 10.3 ‒1.5a)
Gallbladderb) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.8 5.4 5.5 ‒0.1
Pancreas 4.0 4.0 4.0 4.2 4.5 4.5 4.7 4.7 4.8 4.9 4.9 5.0 5.1 2.2a)
Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 ‒7.6a)
Lung 12.4 12.5 12.3 12.6 12.4 13.0 13.5 14.0 13.9 14.2 14.1 14.6 15.1 1.7a)
Breast 20.9 20.9 24.7 27.2 27.8 29.3 32.0 33.3 35.6 37.1 38.7 40.4 43.8 6.3a)
Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.1 12.4 12.2 11.1 11.5 10.6 10.8 10.1 ‒4.0a)
Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.1 5.1 5.3 6.1a)
Ovary 5.0 4.8 4.8 5.0 5.1 5.2 5.4 5.4 5.9 5.6 5.4 5.8 5.7 1.6a)
Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.2 3.0 3.4 6.0a)
Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.6 1.5 1.5 ‒0.8
Brain and CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.7 2.9 2.7 2.6 2.7 2.4 0.3
Thyroid 10.4 10.1 13.2 16.2 21.8 29.5 35.3 43.3 55.6 69.4 80.6 88.6 96.8 23.3a)
Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.4 6.3a)
Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.4 4.4 4.4 4.7 5.1 5.1 5.5 4.5a)
Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.3 1.1 3.9a)
Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.2 4.3 4.2 4.1 4.5 0.9a)
Other and ill-defined 11.8 11.5 11.8 11.5 12.8 13.1 13.9 14.1 14.8 14.9 14.8 15.5 15.7 3.0a)

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p<0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 8
The five major sites of cancer incidence by age group and sex for 2011 in Korea
Rank Age group (yr)

0-14 15-34 35-64 ≥65
Male
 1 Leukemia Thyroid Stomach Lung
(5.0) (12.8) (99.4) (449.8)
 2 Non-Hodgkin lymphoma Colon and rectum Colon and rectum Stomach
(2.0) (3.3) (78.6) (438.4)
 3 Brain and CNS Leukemia Liver Colon and rectum
(1.9) (3.2) (66.5) (355.9)
 4 Kidney Non-Hodgkin lymphoma Thyroid Prostate
(0.5) (3.2) (47.7) (298.1)
 5 Liver Stomach Lung Liver
(0.3) (3.0) (44.1) (202.1)
Female
 1 Leukemia Thyroid Thyroid Colon and rectum
(4.6) (65.1) (234.1) (181.1)
 2 Brain and CNS Breast Breast Stomach
(1.7) (11.0) (117.8) (157.8)
 3 Non-Hodgkin lymphoma Cervix uteri Stomach Lung
(1.4) (5.4) (43.8) (129.0)
 4 Ovary Stomach Colon and rectum Thyroid
(0.8) (3.7) (43.6) (93.6)
 5 Thyroid Ovary Cervix uteri Liver
(0.8) (3.1) (22.0) (77.4)

CNS, central nervous system.

Table 9
Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2011 in Korea
Site/Type Both Male Female



1993-1995 1996-2000 2001-2005 2007-2011 Changea) 1993-1995 1996-2000 2001-2005 2007-2011 Changea) 1993-1995 1996-2000 2001-2005 2007-2011 Changea)
All sites 41.2 44.0 53.8 66.3 25.1 31.7 35.3 45.2 57.6 25.9 53.4 55.3 64.0 75.2 21.8
Lip, oral cavity, and pharynx 41.1 46.7 54.1 61.6 20.5 35.8 41.1 49.3 57.3 21.5 58.1 63.8 67.7 73.2 15.1
Esophagus 12.7 15.2 21.2 30.2 17.5 11.8 14.3 20.4 29.7 17.9 23.7 24.2 29.5 35.4 11.7
Stomach 42.8 46.6 57.7 69.4 26.6 43.0 46.9 58.4 70.1 27.1 42.6 46.0 56.4 67.9 25.3
Colon and rectum 54.8 58.0 66.6 73.8 19.0 55.3 59.0 68.5 75.8 20.5 54.2 56.8 64.1 70.7 16.5
Liver 10.7 13.2 20.2 28.6 17.9 9.9 12.9 20.1 28.5 18.6 13.6 14.2 20.3 28.7 15.1
Gallbladderb) 17.3 19.7 22.8 27.5 10.2 16.6 20.3 23.3 29.0 12.4 18.0 19.1 22.3 26.1 8.1
Pancreas 9.4 7.6 8.0 8.7 -0.7 8.8 7.3 8.0 8.1 -0.7 10.1 8.1 8.1 9.5 -0.6
Larynx 59.7 62.3 66.1 71.7 12.0 60.2 62.8 66.7 72.0 11.8 55.4 57.8 58.2 68.1 12.7
Lung 11.3 12.7 16.2 20.7 9.4 10.4 11.6 15.0 18.3 7.9 14.2 16.2 19.7 26.8 12.6
Breast 77.9 83.2 88.5 91.3 13.4 75.1 85.6 87.0 88.7 13.6 78.0 83.2 88.5 91.3 13.3
Cervix uteri 77.5 80.0 81.3 80.1 2.6 - - - - - 77.5 80.0 81.3 80.1 2.6
Corpus uteri 81.5 81.8 84.6 86.5 5.0 - - - - - 81.5 81.8 84.6 86.5 5.0
Ovary 58.7 58.9 61.4 61.6 2.9 - - - - - 58.7 58.9 61.4 61.6 2.9
Prostate 55.9 67.2 80.1 92.0 36.1 55.9 67.2 80.1 92.0 36.1 - - - - -
Testis 85.4 90.4 90.6 93.2 7.8 85.4 90.4 90.6 93.2 7.8 - - - - -
Kidney 62.0 66.1 73.3 78.8 16.8 60.8 64.4 72.8 78.4 17.6 64.5 69.7 74.5 79.5 15.0
Bladder 69.1 73.1 75.5 75.4 6.3 70.0 74.8 77.3 77.4 7.4 65.5 66.3 68.5 67.0 1.5
Brain and CNS 38.5 39.0 40.6 41.4 2.9 37.2 37.5 40.0 39.3 2.1 40.2 40.7 41.4 43.9 3.7
Thyroid 94.2 94.9 98.3 100.0 5.8 87.2 89.5 95.8 100.1 12.9 95.4 95.9 98.7 99.9 4.5
Hodgkin lymphoma 68.0 71.2 76.7 81.1 13.1 67.6 68.1 74.7 81.1 13.5 68.6 77.4 80.6 81.2 12.6
Non-Hodgkin lymphoma 46.6 50.8 59.9 65.8 19.2 45.3 48.9 58.0 63.9 18.6 48.7 53.5 62.3 68.2 19.5
Multiple myeloma 22.1 19.8 29.3 34.6 12.5 21.1 17.8 29.6 34.6 13.5 23.3 22.1 28.9 34.7 11.4
Leukemia 26.5 33.3 41.8 48.0 21.5 26.2 32.3 41.6 47.3 21.1 26.8 34.6 42.0 48.7 21.9
Other and ill-defined 42.1 45.9 55.8 66.3 24.2 37.4 42.4 52.1 62.4 25.0 47.4 50.0 59.8 70.3 22.9

CNS, central nervous system.

a) Percentage change in 5-year relative survival from 1993 to 1995 and 2007 to 2011,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 10
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2012 in Korea
Site/Type Crude prevalence rate per 100,000a) Age-standardized prevalence rate per 100,000b)


Both Male Female Both Male Female
All sites 2,189.6 1,959.6 2,420.1 1,514.1 1,488.7 1,618.5
Lip, oral cavity, and pharynx 31.0 41.9 20.0 21.7 31.4 13.4
Esophagus 13.6 24.5 2.6 9.1 18.6 1.5
Stomach 377.1 500.5 253.6 252.7 372.7 154.9
Colon and rectum 308.9 367.7 250.0 206.3 276.4 150.7
Liver 95.2 142.3 48.0 66.2 105.6 31.0
Gallbladderc) 27.0 27.5 26.5 17.7 20.8 15.4
Pancreas 12.7 14.0 11.5 8.6 10.6 7.0
Larynx 16.2 30.5 2.0 10.9 23.2 1.2
Lung 97.4 127.0 67.7 65.1 96.2 41.3
Breast 234.8 2.1 468.0 161.1 1.6 316.3
Cervix uteri 82.0 - 164.1 55.8 - 108.4
Corpus uteri 27.1 - 54.2 18.9 - 37.1
Ovary 25.8 - 51.6 18.9 - 37.4
Prostate 84.1 168.1 - 53.0 129.0 -
Testis 3.9 7.9 - 3.6 7.1 -
Kidney 46.0 62.0 30.1 32.5 46.4 20.3
Bladder 47.5 77.2 17.7 30.6 58.7 9.6
Brain and CNS 16.0 16.6 15.4 14.2 15.1 13.3
Thyroid 429.4 132.0 727.4 304.2 94.7 512.0
Hodgkin lymphoma 3.6 4.6 2.6 3.1 3.9 2.3
Non-Hodgkin lymphoma 47.1 51.2 43.1 35.3 40.8 30.6
Multiple myeloma 6.8 7.3 6.3 4.7 5.5 4.0
Leukemia 27.3 30.0 24.6 26.5 29.4 23.6
Other and ill-defined 129.0 124.7 133.2 93.3 100.9 87.2

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2011 and who were alive on January 1, 2012. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using the world standard population,

c) Includes the gallbladder and other/unspecified parts of the biliary tract.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population
      Jean Woo Mok, Yeong Ha Oh, Deepa Magge, Sekhar Padmanabhan
      Gastric Cancer.2024; 27(3): 426.     CrossRef
    • The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments
      Junaid Tantray, Akhilesh Patel, Bhupendra G. Prajapati, Sourabh Kosey, Sankha Bhattacharya
      Current Pharmaceutical Biotechnology.2024; 25(17): 2200.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis
      Zahra Maleki, Mohebat Vali, Hossein-Ali Nikbakht, Soheil Hassanipour, Aida Kouhi, Saman Sedighi, Roya Farokhi, Haleh Ghaem
      BMC Cancer.2023;[Epub]     CrossRef
    • Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk
      Bin Li, Xing Shu, Haoqi Jiang, Change Shi, Le Qi, Lili Zhu, Juanyan Zhou, Min Tang, Anla Hu
      Metabolomics.2023;[Epub]     CrossRef
    • Family Communication About Cancer in Korea: A Dyadic Analysis of Parent-Adolescent Conversation
      Heeyeon Son, Laura E. Miller
      Global Qualitative Nursing Research.2023;[Epub]     CrossRef
    • Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer
      Monika Laszkowska, Han Truong, Adam S. Faye, Judith Kim, Sarah Xinhui Tan, Francesca Lim, Julian A. Abrams, Chin Hur
      Digestive Diseases and Sciences.2022; 67(8): 3693.     CrossRef
    • Genomic differentiation within East Asian Helicobacter pylori
      Yuanhai You, Kaisa Thorell, Lihua He, Koji Yahara, Yoshio Yamaoka, Jeong-Heon Cha, Kazunari Murakami, Yukako Katsura, Ichizo Kobayashi, Daniel Falush, Jianzhong Zhang
      Microbial Genomics .2022;[Epub]     CrossRef
    • Discovery of BRCA1/BRCA2 founder variants by haplotype analysis
      Won Kyung Kwon, Hyeok-Jae Jang, Jeong Eon Lee, Yeon Hee Park, Jai Min Ryu, Jonghan Yu, Ja-Hyun Jang, Jong-Won Kim
      Cancer Genetics.2022; 266-267: 19.     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Comparison of Detection of Epidermal Growth Factor Receptor (EFGR) Gene Mutation in Peripheral Blood Plasma (Liquid Biopsy) with Cytological Specimens in Lung Adenocarcinoma Patients
      Laksmi Wulandari, Gatot Soegiarto, Anna Febriani, Farah Fatmawati, Sahrun
      Indian Journal of Surgical Oncology.2021; 12(S1): 65.     CrossRef
    • Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
      Hyeok Jun Yun, Hee Jun Kim, Jungmin Kim, Sang Yong Kim, Hang-Seok Chang, Cheong Soo Park, Ho-Jin Chang, Ki Cheong Park
      International Journal of Molecular Sciences.2021; 22(2): 536.     CrossRef
    • The utility of high-mobility group A2 overexpression for predicting the prognosis of gastric cancer patients and its contribution to poor prognosis via chemoresistance and the propensity for the occurrence of carcinomatosis peritonei
      Hayemin Lee, Han Hong Lee, Chae Youn Lim, Junhyun Lee
      Surgery.2021; 169(5): 1213.     CrossRef
    • Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
      Iris Lansdorp-Vogelaar, Reinier G.S. Meester, Monika Laszkowska, Fernando Alarid Escudero, Zachary J. Ward, Jennifer M. Yeh
      Best Practice & Research Clinical Gastroenterology.2021; 50-51: 101735.     CrossRef
    • Impact of Posttraumatic Growth and Health Promoting Behavior on Quality of Life in Patients with Gastrointestinal Cancer
      Mi-Ae Kim, Hyun-Ju Lee
      Journal of Korean Academy of Fundamentals of Nursing.2021; 28(1): 32.     CrossRef
    • Apoptotic Effects of Anthocyanins from Vitis coignetiae Pulliat Are Enhanced by Augmented Enhancer of the Rudimentary Homolog (ERH) in Human Gastric Carcinoma MKN28 Cells
      Cheol Park, Won Sup Lee, Se-Il Go, Sang-Ho Jeong, Jiyun Yoo, Hee-Jae Cha, Young-Joon Lee, Heui-Soo Kim, Sun-Hee Leem, Hye Jung Kim, Gon Sup Kim, Soon-Chan Hong, Yung Hyun Choi
      International Journal of Molecular Sciences.2021; 22(6): 3030.     CrossRef
    • Needs and Self-Care Efficacy for Cancer Patients Suffering from Side Effects of Chemotherapy
      Sae'd Abu El-Kass, Marwa M. Ragheb, Safaa' M. Hamed, Anas M. Turkman, Azhar T. Zaki, Guido Bocci
      Journal of Oncology.2021; 2021: 1.     CrossRef
    • Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer
      Jeongmin Lee, Bong Joo Kang, Sung Hun Kim, Pascal A. T. Baltzer
      PLOS ONE.2021; 16(6): e0252476.     CrossRef
    • Overall survival and prognostic factors prostate cancer in Kurdistan Province-Iran: a population-based study (2011-2018)
      Mohammad Aziz Rasouli, Ghobad Moradi, Bushra Zareie, Heshmatollah Sofimajidpour, Sima Tozandehjani, Hedyeh Zafari, Fatemeh Gholami, Sonia Shahsavari, Parisa Hassani, Mahshid Mohammadian
      BMC Cancer.2021;[Epub]     CrossRef
    • Negative Impact of Endoscopic Submucosal Dissection on Short-Term Surgical Outcomes of Subsequent Laparoscopic Distal Gastrectomy for Gastric Cancer
      Hayemin Lee, Han Hong Lee, Kyo Young Song, Cho Hyun Park, Junhyun Lee
      Annals of Surgical Oncology.2020; 27(1): 313.     CrossRef
    • Metabolic comorbidities and medical institution utilization among breast cancer survivors: a national population-based study
      Jaesung Heo, Mison Chun, Young-Taek Oh, O Kyu Noh, Logyoung Kim
      The Korean Journal of Internal Medicine.2020; 35(2): 421.     CrossRef
    • Screening for Upper Gastrointestinal Malignancies in the United States—Which Immigrant Groups Should Be Considered High-Risk?
      Monika Laszkowska, Aaron Oh, Chin Hur
      Gastroenterology.2020; 158(1): 4.     CrossRef
    • MiR‐145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF‐κB pathway regulation
      Gengyu Chen, Ying Gao, Gangpu Wang, Guofeng Dai, Li Tong
      Journal of Cellular Biochemistry.2020; 121(5-6): 3325.     CrossRef
    • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
      Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
      Annals of Global Health.2020; 86(1): 2.     CrossRef
    • Comparison of clinical outcomes according to the history of previous gastrectomy in patients undergoing pancreatoduodenectomy: a propensity score matching analysis
      Jae Ri Kim, Wooil Kwon, Jihoon Chang, Jin-Young Jang, Sun-Whe Kim
      Annals of Surgical Treatment and Research.2020; 98(4): 177.     CrossRef
    • Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer
      Eui Soo Han, Ho Seok Seo, Ji Hyun Kim, Han Hong Lee
      Annals of Surgical Oncology.2020; 27(11): 4216.     CrossRef
    • 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice
      Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Ha-Na Lee, Young-Joon Surh
      Scientific Reports.2020;[Epub]     CrossRef
    • Does Thyroidectomy Impact Quality of Life: Retrospective Case–Control Study of Post-Thyroidectomy Patients and Matched Individuals from the General Population
      Hyeong Won Yu, Ah Reum An, Hye In Kang, Yong Joon Suh, Hyungju Kwon, Su-jin Kim, Young Jun Chai, June Young Choi, Hochun Choi, Kyu Eun Lee, Belong Cho
      Medicina.2020; 56(11): 603.     CrossRef
    • Analysis of risk factors and prevention strategies for functional delayed gastric emptying in 1243 patients with distal gastric cancer
      Tao Pang, Xiao-Yi Yin, Hang-Tian Cui, Zheng-Mao Lu, Ming-Ming Nie, Kai Yin, Guo-En Fang, Tian-Hang Luo, Xu-Chao Xue
      World Journal of Surgical Oncology.2020;[Epub]     CrossRef
    • Effect of Korean Red Ginseng extract on colorectal lung metastasis through inhibiting the epithelial–mesenchymal transition via transforming growth factor-β1/Smad-signaling-mediated Snail/E-cadherin expression
      Ji-Ye Kee, Yo-Han Han, Jeong-Geon Mun, Seong-Hwan Park, Hee Dong Jeon, Seung-Heon Hong
      Journal of Ginseng Research.2019; 43(1): 68.     CrossRef
    • INC280 inhibits Wnt/β-catenin and EMT signaling pathways and its induce apoptosis in diffuse gastric cancer positive for c-MET amplification
      Sung-Hwa Sohn, Bohyun Kim, Hee Jung Sul, Yoo Jin Kim, Hyeong Su Kim, Hongtae Kim, Jong Bok Seo, Youngho Koh, Dae Young Zang
      BMC Research Notes.2019;[Epub]     CrossRef
    • Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice
      Chin-Hee Song, Nayoung Kim, Sun Min Lee, Ryoung Hee Nam, Soo In Choi, So Ra Kang, Eun Shin, Dong Ho Lee, Ha-Na Lee, Young-Joon Surh
      Biochemical Pharmacology.2019; 164: 139.     CrossRef
    • Evaluation of Absorbed Dose According to Nanoparticle Density During the Breast Cancer Brachytherapy
      Deuk-Hee Lee, Ji-Hee Nam, Jung-Hoon Kim
      Journal of Radiological Science and Technology.2019; 42(2): 131.     CrossRef
    • Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians
      Ga Eun Nam, Kyung Hwan Cho, Kyungdo Han, Chul Min Kim, Byoungduck Han, Sung Jung Cho, Seung Jin Jung, Yeongkeun Kwon, Yang Hyun Kim, Do Hoon Kim, Seon Mee Kim, Youn Seon Choi, Yong Kyun Roh, Yong Gyu Park
      British Journal of Cancer.2019; 121(3): 271.     CrossRef
    • Sexual dimorphism in the incidence of human cancers
      Daoshan Zheng, Justyna Trynda, Cecilia Williams, Jeremy A. Vold, Justin H. Nguyen, Denise M. Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin, Zhaoyu Li
      BMC Cancer.2019;[Epub]     CrossRef
    • Synergistic combination of DT‐13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC‐823 cells via NM IIA/EGFR/HK II axis
      Xiao‐Wen Yu, Dandan Wei, Ying‐Sheng Gao, Hong‐Zhi Du, Bo‐Yang Yu, Rui‐Ming Li, Chang‐Min Qian, Xue‐Jun Luo, Sheng‐Tao Yuan, Jun‐Song Wang, Li Sun
      Journal of Cellular and Molecular Medicine.2019; 23(10): 6622.     CrossRef
    • Quality of Life and Supportive Care Needs of Back-to-Work Breast Cancer Survivors
      Su Jeong Han, Hye Won Kim, Dae Sung Yoon, Mi Ran Kim
      Korean Journal of Adult Nursing.2019; 31(5): 552.     CrossRef
    • A study on Polycyclic Aromatic Hydrocarbons Analysis Presented in the Residential Environment
      Sang-Ho Ko, Tae-Sook Lim
      Journal of Environmental Analysis, Health and Toxicology.2019; 22(4): 242.     CrossRef
    • MUDENG Expression Profiling in Cohorts and Brain Tumor Biospecimens to Evaluate Its Role in Cancer
      Juhyun Shin, Jun-Ha Choi, Seunghwa Jung, Somi Jeong, Jeongheon Oh, Do-Young Yoon, Man Hee Rhee, Jaehong Ahn, Se-Hyuk Kim, Jae-Wook Oh
      Frontiers in Genetics.2019;[Epub]     CrossRef
    • A qualitative study of healthcare providers’ perceptions and suggestions for developing cancer survivorship care models in South Korea
      J.W. Lim, E.J. Shon, E.J. Yang
      European Journal of Cancer Care.2018; 27(1): e12613.     CrossRef
    • A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors
      Eunyoung Park, Junghee Yoon, Eun-kyung Choi, Im Ryung Kim, Danbee Kang, Se-Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn, Adriaan Visser, Juhee Cho
      BMC Cancer.2018;[Epub]     CrossRef
    • Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a U.S. population
      Alyssa Y. Choi, Lisa L. Strate, Matthew C. Fix, Rodney A. Schmidt, Alexander R. Ende, Matthew M. Yeh, John M. Inadomi, Joo Ha Hwang
      Gastrointestinal Endoscopy.2018; 87(4): 1023.     CrossRef
    • Clinicopathologic risk factors for right paraesophageal lymph node metastasis in patients with papillary thyroid carcinoma
      Q. A. Yu, D. K. Ma, K. P. Liu, P. Wang, C. M. Xie, Y. H. Wu, W. J. Dai, H. C. Jiang
      Journal of Endocrinological Investigation.2018; 41(11): 1333.     CrossRef
    • In silico and in vitro analysis of coumarin derivative induced anticancer effects by undergoing intrinsic pathway mediated apoptosis in human stomach cancer
      Haribalan Perumalsamy, Karuppasamy Sankarapandian, Karpagam Veerappan, Sathishkumar Natarajan, Narendran Kandaswamy, Lakshmi Thangavelu, Sri Renukadevi Balusamy
      Phytomedicine.2018; 46: 119.     CrossRef
    • Validation of a Questionnaire to Delineate the Clinical Trial Nursing Roles in Korea
      In Jung Choi, Hye-Ja Park
      Cancer Nursing.2018; 41(3): E30.     CrossRef
    • Changes in Oral Microbiota in Patients Receiving Radical Concurrent Chemoradiotherapy for The Head and Neck Squamous Cell Carcinoma
      Jin Ho Kim, Yoon Hee Choi, Soo-Youn An, Hee Young Son, Chulwon Choi, Seyeon Kim, Jin Chung, Hee Sam Na
      International Journal of Oral Biology.2018; 43(1): 13.     CrossRef
    • Optimal Endoscopic Screening Interval for Early Detection of Gastric Cancer: a Single-Center Study
      Sun Jin, Seong Woo Jeon, Yonghwan Kwon, Su Youn Nam, Seong Jae Yeo, Sang Hoon Kwon, Sang Jik Lee
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • The Flavonoid Jaceosidin from Artemisia princeps Induces Apoptotic Cell Death and Inhibits the Akt Pathway in Oral Cancer Cells
      Hye-Yeon Han, Hyung Joon Kim, Seung-Hwa Jeong, Jiyeon Kim, Sung-Hee Jeong, Gyoo Cheon Kim, Dae-Seok Hwang, Uk-Kyu Kim, Mi Heon Ryu, Solomon Habtemariam
      Evidence-Based Complementary and Alternative Medicine.2018;[Epub]     CrossRef
    • Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients
      Sang Hyun Shin, Song Cheol Kim, Ki-Byung Song, Dae Wook Hwang, Jae Hoon Lee, Kwang-Min Park, Young-Joo Lee
      Surgery.2018; 164(3): 432.     CrossRef
    • Estimation of the medical need for carbon-ion radiotherapy in Korea
      Ilsung Cho, Young Seok Seo, WonGyun Jung, Mi-sook Kim
      Journal of Radiation Research.2018; 59(5): 588.     CrossRef
    • Thyroid cancer among female workers in Korea, 2007–2015
      Seonghoon Kang, Jinho Song, Taehwan Koh, One Park, Jong-Tae Park, Won-Jin Lee
      Annals of Occupational and Environmental Medicine.2018;[Epub]     CrossRef
    • Efficacy and Safety of Robotic Procedures Performed Using the da Vinci Robotic Surgical System at a Single Institute in Korea: Experience with 10000 Cases
      Dong Hoon Koh, Won Sik Jang, Jae Won Park, Won Sik Ham, Woong Kyu Han, Koon Ho Rha, Young Deuk Choi
      Yonsei Medical Journal.2018; 59(8): 975.     CrossRef
    • Safety of Laparoscopic Radical Gastrectomy in Gastric Cancer Patients with End-Stage Renal Disease
      Hayemin Lee, Cho Hyun Park, Seung Man Park, Wook Kim, Hyung Min Chin, Jin Jo Kim, Kyo Young Song, Sung Geun Kim, Kyong Hwa Jun, Jeong Goo Kim, Han Hong Lee, Junhyun Lee, Dong Jin Kim
      Journal of Gastric Cancer.2018; 18(3): 287.     CrossRef
    • Germline Variants in MLH1, MSH2, and MSH6 in Korean Patients with Lynch Syndrome
      Kyoung-Jin Park, Dong Kyung Chang, Hee Cheol Kim, Jong-Won Kim
      Laboratory Medicine Online.2018; 8(4): 156.     CrossRef
    • Change in the Prevalences and Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in Korea: Multicenter Clinical Trials
      Young-Jae Hwang, Nayoung Kim, Sung Eun Kim, Gwang Ho Baik, Ju Yup Lee, Kyung Sik Park, Young-Eun Joo, Dae-Seong Myung, Hyeon Ju Kim, Hyun Joo Song, Heung Up Kim, Kwangwoo Nam, Jeong Eun Shin, Hyun Jin Kim, Gwang Ha Kim, Jongchan Lee, Seon Hee Lim, Geom Se
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2018; 18(4): 247.     CrossRef
    • Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer
      Young Ju Jung, In-Jae Oh, Youndong Kim, Jong Ha Jung, Minkyoung Seok, Woochang Lee, Cheol Kyu Park, Jung-Hwan Lim, Young-Chul Kim, Woo-Sung Kim, Chang-Min Choi
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Microbiome of Hepatobiliary Diseases
      Yeseul Kim, Dongho Choi
      Hanyang Medical Reviews.2018; 38(2): 80.     CrossRef
    • Trace Element Contents in Thyroid Cancer Investigated by Instrumental Neutron Activation Analysis

      Journal of Oncology Research.2018; 1(1): 1.     CrossRef
    • Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer
      Feng Li, Janice M Yoshizawa, Kyoung-Mee Kim, Julie Kanjanapangka, Tristan R Grogan, Xiaoyan Wang, David E Elashoff, Shigeo Ishikawa, David Chia, Wei Liao, David Akin, Xinmin Yan, Min-Sun Lee, Rayun Choi, Su-Mi Kim, So-Young Kang, Jae-Moon Bae, Tae-Sung So
      Clinical Chemistry.2018; 64(10): 1513.     CrossRef
    • Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB–IV gastric cancer
      Shinkyo Yoon, Changhoon Yoo, Min-Hee Ryu, Myoung Joo Kang, Baek-Yeol Ryoo, Sook Ryun Park, Jeong Hwan Yook, Sung Tae Oh, Moon-Won Yoo, Byung Sik Kim, Yoon-Koo Kang
      Gastric Cancer.2017; 20(1): 182.     CrossRef
    • Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer
      Yumun Jeong, Jae Lyun Lee
      Asia-Pacific Journal of Clinical Oncology.2017; 13(3): 204.     CrossRef
    • Breast, prostate, and thyroid cancer screening tests and overdiagnosis
      Minsoo Jung
      Current Problems in Cancer.2017; 41(1): 71.     CrossRef
    • Helicobacter pylori infection is an independent risk factor for colonic adenomatous neoplasms
      Ji Hyung Nam, Chang Won Hong, Byung Chang Kim, Aesun Shin, Kum Hei Ryu, Bum Joon Park, Bun Kim, Dae Kyung Sohn, Kyung Su Han, Jeongseon Kim, Chan Wha Lee
      Cancer Causes & Control.2017; 28(2): 107.     CrossRef
    • Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer
      Shigeomi Takeda, Suguru Yamada, Norifumi Hattori, Kae Nakamura, Hiromasa Tanaka, Hiroaki Kajiyama, Mitsuro Kanda, Daisuke Kobayashi, Chie Tanaka, Tsutomu Fujii, Michitaka Fujiwara, Masaaki Mizuno, Masaru Hori, Yasuhiro Kodera
      Annals of Surgical Oncology.2017; 24(5): 1188.     CrossRef
    • Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma
      Eun Young Kim, Kee Hoon Hyun, Yong Lai Park, Chan Heun Park, Ji-Sup Yun
      Annals of Surgical Treatment and Research.2017; 92(1): 1.     CrossRef
    • Information-sharing challenges between adolescents with cancer, their parents and health care providers: a qualitative study
      Masoud Bahrami, Mahboobeh Namnabati, Fariborz Mokarian, Parastoo Oujian, Paul Arbon
      Supportive Care in Cancer.2017; 25(5): 1587.     CrossRef
    • Trends in thyroid cancer incidence and mortality in Portugal
      Luís Raposo, Samantha Morais, Maria J. Oliveira, Ana P. Marques, Maria José Bento, Nuno Lunet
      European Journal of Cancer Prevention.2017; 26(2): 135.     CrossRef
    • Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study
      Sang Gyun Kim, Seon Mi Ji, Na Rae Lee, Seung-Hee Park, Ji Hye You, Il Ju Choi, Wan Sik Lee, Seun Ja Park, Jun Haeng Lee, Sang-Yong Seol, Ji Hyun Kim, Chul-Hyun Lim, Joo Young Cho, Gwang Ha Kim, Hoon Jai Chun, Yong Chan Lee, Hwoon-Yong Jung, Jae J. Kim
      Gut and Liver.2017; 11(1): 87.     CrossRef
    • Is it beneficial to perform surgical resection in elderly patients more than 80 years old with advanced gastric cancer?
      Jin Woo Choo, Yeonmi Ju, Hyun Lim, Sung Hee Youn, Jae Seung Soh, Ji Won Park, Ho Suk Kang, Sung Eun Kim, Sung Hoon Moon, Jong Hyeok Kim, Choong Kee Park, Hong Il Ha, Min-Jeong Kim, Kab-Choong Kim, Ji Woong Cho
      Scandinavian Journal of Gastroenterology.2017; 52(10): 1057.     CrossRef
    • Safety of laparoscopic radical gastrectomy in gastric cancer patients with liver cirrhosis
      Dong Jin Kim, Cho Hyun Park, Wook Kim, Hyung Min Jin, Jin Jo Kim, Han Hong Lee, Jun Hyun Lee
      Surgical Endoscopy.2017; 31(10): 3898.     CrossRef
    • Cutaneous Implantation Metastasis of Papillary Thyroid Carcinoma Following Fine Needle Aspiration Biopsy
      Chan Ho Na, Dong Jin Kim, Min Sung Kim, Bong Seok Shin
      Annals of Dermatology.2017; 29(1): 123.     CrossRef
    • Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor
      Danbee Kang, Im‐Ryung Kim, Eun‐Kyung Choi, Jung Hee Yoon, Se‐Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Wonshik Han, Dong‐Young Noh, Juhee Cho
      Psycho-Oncology.2017; 26(11): 1922.     CrossRef
    • Epidemiology and treatment patterns of epithelial ovarian cancer
      Philip Jessmon, Talia Boulanger, Wei Zhou, Pallavi Patwardhan
      Expert Review of Anticancer Therapy.2017; 17(5): 427.     CrossRef
    • Bilateral Axillo‐Breast Approach Robotic Thyroidectomy (BABA RT) Does Not Interfere with Breast Image Follow‐Up
      Hyeong Won Yu, Young Jun Chai, Hyungju Kwon, Su‐jin Kim, June Young Choi, Kyu Eun Lee
      World Journal of Surgery.2017; 41(8): 2020.     CrossRef
    • PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Th
      Hiroji Iwata, Seock-Ah Im, Norikazu Masuda, Young-Hyuck Im, Kenichi Inoue, Yoshiaki Rai, Rikiya Nakamura, Jee Hyun Kim, Justin T. Hoffman, Ke Zhang, Carla Giorgetti, Shrividya Iyer, Patrick T. Schnell, Cynthia Huang Bartlett, Jungsil Ro
      Journal of Global Oncology.2017; 3(4): 289.     CrossRef
    • Obesity Markers as Predictors for Colorectal Neoplasia
      Jin-Hyun Kwon, Hae-Jin Ko, Chang-Ho Youn, Hye-In Choi
      Journal of Obesity & Metabolic Syndrome.2017; 26(1): 28.     CrossRef
    • Clinical features of recently diagnosed papillary thyroid carcinoma in elderly patients aged 65 and older based on 10 years of sonographic experience at a single institution in Korea
      Eun Sil Kim, Younghen Lee, Hyungsuk Seo, Gil Soo Son, Soon Young Kwon, Young-Sik Kim, Ji-A Seo, Nan Hee Kim, Sang-il Suh, Inseon Ryoo, Sung-Hye You
      Ultrasonography.2017; 36(4): 355.     CrossRef
    • Transoral endoscopic thyroidectomy: our initial experience using a new endoscopic technique
      Jun-Ook Park, Dong-Il Sun
      Surgical Endoscopy.2017; 31(12): 5436.     CrossRef
    • Can Endoscopic Bleeding Control Improve the Prognosis of Advanced Gastric Cancer Patients?
      Hyungchul Park, Ji Yong Ahn, Hwoon-Yong Jung, Joo Hyun Chun, Kwangwoo Nam, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim
      Journal of Clinical Gastroenterology.2017; 51(7): 599.     CrossRef
    • Incidence of Pathological Downgrading and Treatment Outcome After Radical Prostatectomy in Patients With Biopsy Confirmed High Gleason Score Prostate Cancer
      Jun Phil Na, Jae Ho Yoo, Tae Heon Kim, Min Yong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Hyun Moo Lee, Han Yong Choi, Seong Soo Jeon
      The Korean Journal of Urological Oncology.2017; 15(2): 79.     CrossRef
    • The Prevalence of Depression among Patients with the Top Ten Most Common Cancers in South Korea
      Boram Park, Soyoung Youn, Ki-Kyung Yi, Su-yeon Lee, Jung-Sun Lee, Seockhoon Chung
      Psychiatry Investigation.2017; 14(5): 618.     CrossRef
    • β-Lapachone Inhibits Lung Metastasis of Colorectal Cancer by Inducing Apoptosis of CT26 Cells
      Ji-Ye Kee, Yo-Han Han, Jinbong Park, Dae-Seung Kim, Jeong-Geon Mun, Kwang Seok Ahn, Hyun-Jung Kim, Jae-Young Um, Seung-Heon Hong
      Integrative Cancer Therapies.2017; 16(4): 585.     CrossRef
    • Clinical features of gastric emptying after distal gastrectomy
      Dae Hoon Kim, Hyo Yung Yun, Young-Jin Song, Dong Hee Ryu, Hye-Suk Han, Joung-Ho Han, Ki Bae Kim, Soon Man Yoon, Sei Jin Youn
      Annals of Surgical Treatment and Research.2017; 93(6): 310.     CrossRef
    • Cytopathologic Features in Papillary Thyroid Cancer Arising From Benign Nodular Disease
      Su Yun Choi, Jin Chul Jung, Eun Sook Nam
      International Surgery.2017; 102(3-4): 165.     CrossRef
    • Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
      Jisook Park, Eunjung Lee, Kyoung-Jin Park, Hyung-Doo Park, Jong-Won Kim, Hye In Woo, Kwang Hyuck Lee, Kyu-Taek Lee, Jong Kyun Lee, Joon-Oh Park, Young Suk Park, Jin Seok Heo, Seong Ho Choi, Dong Wook Choi, Kee-Taek Jang, Soo-Youn Lee
      Oncotarget.2017; 8(26): 42761.     CrossRef
    • Effects of alcohol consumption, ALDH2 rs671 polymorphism, and Helicobacter pylori infection on the gastric cancer risk in a Korean population
      Sarah Yang, Jeonghee Lee, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Joohon Sung, Jeongseon Kim
      Oncotarget.2017; 8(4): 6630.     CrossRef
    • Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project
      Bo Hwa Sohn, Jun-Eul Hwang, Hee-Jin Jang, Hyun-Sung Lee, Sang Cheul Oh, Jae-Jun Shim, Keun-Wook Lee, Eui Hyun Kim, Sun Young Yim, Sang Ho Lee, Jae-Ho Cheong, Woojin Jeong, Jae Yong Cho, Joohee Kim, Jungsoo Chae, Jeeyun Lee, Won Ki Kang, Sung Kim, Sung Hoo
      Clinical Cancer Research.2017; 23(15): 4441.     CrossRef
    • Increasing thyroid cancer incidence in Queensland, Australia 1982–2008 – true increase or overdiagnosis?
      N. Pandeya, D.S. McLeod, K. Balasubramaniam, P.D. Baade, P.H. Youl, C.J. Bain, R. Allison, S.J. Jordan
      Clinical Endocrinology.2016; 84(2): 257.     CrossRef
    • A Case of von Hippel–Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
      Su Jin Heo, Choong-kun Lee, Kyu Yeon Hahn, Gyuri Kim, Hyuk Hur, Sung Hoon Choi, Kyung Seok Han, Arthur Cho, Minkyu Jung
      Cancer Research and Treatment.2016; 48(1): 409.     CrossRef
    • Cancer literacy as a mediator for cancer screening behaviour in Korean adults
      Hee Yun Lee, Taeho Greg Rhee, Nam Keol Kim
      Health & Social Care in the Community.2016; 24(5): e34.     CrossRef
    • Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer
      Hyo Sook Bae, Myong Cheol Lim, Jeong Seon Lee, Yumi Lee, Byung Ho Nam, Sang-Soo Seo, Sokbom Kang, Seung Hyun Chung, Joo-Young Kim, Sang-Yoon Park
      Annals of Surgical Oncology.2016; 23(1): 186.     CrossRef
    • Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013
      Mina Suh, Kui Son Choi, Boyoung Park, Yoon Young Lee, Jae Kwan Jun, Duk-Hyoung Lee, Yeol Kim
      Cancer Research and Treatment.2016; 48(1): 1.     CrossRef
    • An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer
      Jung-Yun Lee, Jina Youm, Jae Weon Kim, Kidong Kim, Hak Jae Kim, Jeong Yeon Cho, Min A Kim, Noh Hyun Park, Yong-Sang Song
      Cancer Research and Treatment.2016; 48(1): 259.     CrossRef
    • Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence‐free survival of medullary thyroid cancer: a large‐scale retrospective analysis over 30 years
      Kyong Yeun Jung, Seok‐Mo Kim, Won Sang Yoo, Bup‐Woo Kim, Yong Sang Lee, Kyung Won Kim, Kyu Eun Lee, Jong Ju Jeong, Kee‐Hyun Nam, Se Hoon Lee, Jeong Hun Hah, Woong Youn Chung, Ka Hee Yi, Do Joon Park, Yeo‐Kyu Youn, Myung‐Whun Sung, Bo Youn Cho, Cheong Soo
      Clinical Endocrinology.2016; 84(4): 587.     CrossRef
    • Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea
      Yunhee Choi, Yeonju Kim, Sue K. Park, Hai-Rim Shin, Keun-Young Yoo
      Cancer Research and Treatment.2016; 48(1): 11.     CrossRef
    • Some Elements in Thyroid Tissue are Associated with More Advanced Stage of Thyroid Cancer in Korean Women
      Hye-Kyung Chung, Ji Sun Nam, Chul Woo Ahn, Yong Sang Lee, Kyung Rae Kim
      Biological Trace Element Research.2016; 171(1): 54.     CrossRef
    • Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods
      Eun-Jung Cho, Hyun-Ki Kim, Tae-Dong Jeong, Dae-Hyun Ko, Suh Eun Bae, Jong-Soo Lee, Woochang Lee, Jae Won Choe, Sail Chun, Hwoon-Yong Jung, Won-Ki Min
      Clinica Chimica Acta.2016; 452: 149.     CrossRef
    • Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma
      Lei Zhang, Hongfeng Liu, Yong Xie, Yu Xia, Bo Zhang, Guangliang Shan, Xiaoyi Li
      European Journal of Surgical Oncology (EJSO).2016; 42(1): 81.     CrossRef
    • Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death
      Yoo Seob Shin, Hyun Young Cha, Bok-Soon Lee, Sung Un Kang, Hye Sook Hwang, Hak Cheol Kwon, Chul-Ho Kim, Eun Chang Choi
      Cancer Research and Treatment.2016; 48(2): 738.     CrossRef
    • Population-Based Regional Cancer Incidence in Korea: Comparison between Urban and Rural Areas
      Haa-Na Song, Se-Il Go, Won Sup Lee, Yire Kim, Hye Jung Choi, Un Seok Lee, Myoung Hee Kang, Gyeong-Won Lee, Hoon-Gu Kim, Jung Hun Kang, Yune Sik Kang, Jeong-Hee Lee, Jin-Myung Jung, Soon Chan Hong
      Cancer Research and Treatment.2016; 48(2): 789.     CrossRef
    • Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
      Kyung-Goo Lee, Hyuk-Joon Lee, Seung-Young Oh, Jun-Young Yang, Hye-Seong Ahn, Yun-Suhk Suh, Seong-Ho Kong, Tae-Yong Kim, Do-Youn Oh, Seock-Ah Im, Kuhn Uk Lee, Woo Ho Kim, Yung-Jue Bang, Han-Kwang Yang
      Annals of Surgical Oncology.2016; 23(4): 1234.     CrossRef
    • Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience
      Jun Hee Lee, Yang Won Min, Jun Haeng Lee, Eun Ran Kim, Hyuk Lee, Byung-Hoon Min, Jae J. Kim, Kee-Taek Jang, Kyoung-Mee Kim, Cheol Keun Park
      Surgical Endoscopy.2016; 30(9): 3987.     CrossRef
    • Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer
      Feng-qi Nie, Shijie Ma, Min Xie, Yan-wen Liu, Wei De, Xiang-hua Liu
      Tumor Biology.2016; 37(6): 7693.     CrossRef
    • The caspase 3-dependent apoptotic effect of pycnogenol in human oral squamous cell carcinoma HSC-3 cells
      In-Hyoung Yang, Ji-Ae Shin, Lee-Han Kim, Ki Han Kwon, Sung-Dae Cho
      Journal of Clinical Biochemistry and Nutrition.2016; 58(1): 40.     CrossRef
    • Comparison of two- and three-dimensional sonography for the prediction of the extrathyroidal extension of papillary thyroid carcinomas
      Yang Seon Yi, Sang Soo Kim, Won Jin Kim, Min Jung Bae, Ji Hyun Kang, Bo Gwang Choi, Yun Kyung Jeon, Bo Hyun Kim, Byung Joo Lee, Soo Geun Wang, In Joo Kim, Yong Ki Kim
      The Korean Journal of Internal Medicine.2016; 31(2): 313.     CrossRef
    • CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
      Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Rock Bum Kim, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
      Cancer Research and Treatment.2016; 48(1): 142.     CrossRef
    • Prevalence rate and clinical characteristics of esophageal ectopic sebaceous glands in asymptomatic health screen examinees
      Areum Park, Jung-Hyun Lee, Ayoung Park, Young-Hwan Jung, Hyung-Jun Chu, Sang-Su Bae, Jeong-Kwon Kim, Won-Yong Kim, Byung-Kook Kim
      Diseases of the Esophagus.2016; : n/a.     CrossRef
    • Leptomeningeal metastasis: Clinical experience of 519 cases
      Jae-Won Hyun, In Hye Jeong, AeRan Joung, Hyo Jin Cho, Su-Hyun Kim, Ho Jin Kim
      European Journal of Cancer.2016; 56: 107.     CrossRef
    • Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
      Dong Soo Lee, Yeon S. Kim, Chul S. Kay, Sung H. Kim, Chang D. Yeo, Jin W. Kim, Seung Joon Kim, Young K. Kim, Yoon H. Ko, Jin H. Kang, Kyo Y. Lee
      Medicine.2016; 95(6): e2795.     CrossRef
    • Survival Benefit of Early Cancer Detection Through Regular Endoscopic Screening for De Novo Gastric and Colorectal Cancers in Korean Liver Transplant Recipients
      D.H. Jung, S. Hwang, G.W. Song, C.S. Ahn, D.B. Moon, T.Y. Ha, K.H. Kim, G.C. Park, B.S. Kim, I.J. Park, S.B. Lim, J.C. Kim, M.W. Yoo, J.S. Byeon, H.Y. Jung, G.H. Lee, S.J. Myung, J. Choe, J.Y. Choi, H.W. Park, S.G. Lee
      Transplantation Proceedings.2016; 48(1): 145.     CrossRef
    • Incidence and Survival of Childhood Cancer in Korea
      Hyeon Jin Park, Eun-Kyeong Moon, Ju Young Yoon, Chang-Mo Oh, Kyu-Won Jung, Byung Kiu Park, Hee Young Shin, Young-Joo Won
      Cancer Research and Treatment.2016; 48(3): 869.     CrossRef
    • Mammographic Breast Density Evaluation in Korean Women Using Fully Automated Volumetric Assessment
      Inyoung Youn, SeonHyeong Choi, Shin Ho Kook, Yoon Jung Choi
      Journal of Korean Medical Science.2016; 31(3): 457.     CrossRef
    • The potential of deferasirox as a novel therapeutic modality in gastric cancer
      Jung Hye Choi, Jung Soon Kim, Young Woong Won, Jieun Uhm, Byeong Bae Park, Young Yiul Lee
      World Journal of Surgical Oncology.2016;[Epub]     CrossRef
    • A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population
      Seil Sohn, Jinhee Kim, Chun Kee Chung, Na Rae Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
      The Spine Journal.2016; 16(8): 937.     CrossRef
    • Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary
      Jeong-Yeol Park, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      International Journal of Gynecology & Obstetrics.2016; 134(1): 49.     CrossRef
    • Improvement of clinical outcomes in the patients with gallbladder cancer: lessons from periodic comparison in a tertiary referral center
      Jihoon Chang, Jin‐Young Jang, Kyoung Bun Lee, Mee Joo Kang, Woohyun Jung, Yong Chan Shin, Sun‐Whe Kim
      Journal of Hepato-Biliary-Pancreatic Sciences.2016; 23(4): 234.     CrossRef
    • Management of long-term colorectal cancer survivors in Korea
      Hee-Taik Kang, Hyun Jung Bahk, Jae-Yong Shim, Nam Kyu Kim
      Journal of the Korean Medical Association.2016; 59(4): 276.     CrossRef
    • Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors
      Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      Annals of Surgical Oncology.2016; 23(9): 2982.     CrossRef
    • Lung Cancer in Homeless People: Clinical Outcomes and Cost Analysis in a Single Institute
      Koung Jin Suh, Ki Hwan Kim, Jin Lim, Jin Hyun Park, Jin-Soo Kim, In Sil Choi
      Canadian Respiratory Journal.2016; 2016: 1.     CrossRef
    • One-Year Experience Managing a Cancer Survivorship Clinic Using a Shared-Care Model for Gastric Cancer Survivors in Korea
      Ji Eun Lee, Dong Wook Shin, Hyejin Lee, Ki Young Son, Warrick Junsuk Kim, Yun-Suhk Suh, Seong-Ho Kong, Hyuk Joon Lee, Belong Cho, Han-Kwang Yang
      Journal of Korean Medical Science.2016; 31(6): 859.     CrossRef
    • Prognostic significance of CEA expression by RT-PCR in peritoneal wash from patients with gastric cancer: result of a 5-year follow-up after curative resection
      Hyun-Dong Chae, In-Hwan Kim
      Scandinavian Journal of Gastroenterology.2016; 51(8): 956.     CrossRef
    • Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis
      Changhoon Yoo, Min-Hee Ryu, Young-Soon Na, Baek-Yeol Ryoo, Chae-Won Lee, Yoon-Koo Kang
      British Journal of Cancer.2016; 114(11): 1185.     CrossRef
    • Association between reduction in copayment and gastric cancer patient concentration to the capital area in South Korea: NHI cohort 2003–2013
      Kyu-Tae Han, Jeeyun Kim, Chung Mo Nam, Ki Tae Moon, Sang Gyu Lee, Seung Ju Kim, Yeong Jun Ju, Jeoung A Kwon, Sun Jung Kim, Woorim Kim, Eun-Cheol Park
      Health Policy.2016; 120(6): 580.     CrossRef
    • Changes in the types of liver diseases requiring hepatic resection: a single-institution experience of 9016 cases over a 10-year period
      Hwui-Dong Cho, Shin Hwang, Young-Joo Lee, Kwang-Min Park, Ki-Hun Kim, Jin Cheon Kim, Chul-Soo Ahn, Deok-Bog Moon, Tae-Yong Ha, Sung-Gyu Lee
      Korean Journal of Hepato-Biliary-Pancreatic Surgery.2016; 20(2): 49.     CrossRef
    • NKX6.3 Is a Transcription Factor for Wnt/β-catenin and Rho-GTPase Signaling-Related Genes to Suppress Gastric Cancer Progression
      Jung Hwan Yoon, Jung Woo Eun, Won Suk Choi, Olga Kim, Suk Woo Nam, Jung Young Lee, Won Sang Park
      EBioMedicine.2016; 9: 97.     CrossRef
    • Nuclear Medicine in Pediatric and Adolescent Tumors
      Pınar Özgen Kiratli, Murat Tuncel, Zvi Bar-Sever
      Seminars in Nuclear Medicine.2016; 46(4): 308.     CrossRef
    • Evaluation of Machine Learning Algorithm Utilization for Lung Cancer Classification Based on Gene Expression Levels
      Maxim D Podolsky, Anton A Barchuk, Vladimir I Kuznetcov, Natalia F Gusarova, Vadim S Gaidukov, Segrey A Tarakanov
      Asian Pacific Journal of Cancer Prevention.2016; 17(2): 835.     CrossRef
    • Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer
      Shinkyo Yoon, Byung Woog Kang, Su Yeon Park, Hye Jin Kim, Jun Seok Park, Gyu Seog Choi, Jong Gwang Kim
      Journal of Cancer Research and Clinical Oncology.2016; 142(8): 1775.     CrossRef
    • The clinical utilization of radiation therapy in Korea between 2009 and 2013
      Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Young Seok Seo, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Hyun Jin Song
      Radiation Oncology Journal.2016; 34(2): 88.     CrossRef
    • Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
      Michael Carlberg, Lena Hedendahl, Mikko Ahonen, Tarmo Koppel, Lennart Hardell
      BMC Cancer.2016;[Epub]     CrossRef
    • Knowledge of HPV and Surgery among Women Who Underwent Cervical Conization: A Korean Multi-Center Study
      So Yeun Jun, Se Ik Kim, Myong Cheol Lim, Jung-Yun Lee, San Hui Lee, Yong Jung Song, Kyoung-Chul Chun, Jae Weon Kim, Sang-Yoon Park
      Yonsei Medical Journal.2016; 57(5): 1222.     CrossRef
    • High levels of carcinoembryonic antigen and smoking might be markers of colorectal adenoma in Korean males aged 40-49 years
      In Cheol Yoon, Jeong Hyeon Cho, Heejin Choi, Young Hoon Choi, Kyu Min Lim, Sung Hwa Choi, Jae Ho Han, Hyeon Ju Jeong, Hong Sub Lee
      Yeungnam University Journal of Medicine.2016; 33(1): 13.     CrossRef
    • Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study
      Jinsung Park, Beomseok Suh, Dong Wook Shin, Jun Hyuk Hong, Hanjong Ahn
      Cancer Research and Treatment.2016; 48(3): 899.     CrossRef
    • Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX
      Mi-Jung Kim, Sae-Won Han, Dae-Won Lee, Yongjun Cha, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Se Hyung Kim, Seock-Ah Im, Yung-Jue Bang, Tae-You Kim
      Cancer Research and Treatment.2016; 48(3): 990.     CrossRef
    • Risk factors for lymph node metastasis in papillary thyroid microcarcinoma: Older patients with fewer lymph node metastases
      L. Zhang, J. Yang, Q. Sun, Y. Liu, F. Liang, Z. Liu, G. Chen, S. Chen, Z. Shang, Y. Li, X. Li
      European Journal of Surgical Oncology (EJSO).2016; 42(10): 1478.     CrossRef
    • Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
      Yoo Seob Shin, Sung Un Kang, Ju Kyeong Park, Yang Eun Kim, Yeon Soo Kim, Seung Joon Baek, Seong-Ho Lee, Chul-Ho Kim
      Phytomedicine.2016; 23(12): 1344.     CrossRef
    • Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
      Yaewon Yang, Seock-Ah Im, Bhumsuk Keam, Kyung‑Hun Lee, Tae‑Yong Kim, Koung Jin Suh, Han Suk Ryu, Hyeong-Gon Moon, Sae‑Won Han, Do‑Youn Oh, Wonshik Han, Tae‑You Kim, In Ae Park, Dong-Young Noh
      BMC Cancer.2016;[Epub]     CrossRef
    • High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
      Ji Soo Park, Hong Jae Chon, Hei-Cheul Jeung, Sang Joon Shin, Sun Young Rha, Joong Bae Ahn, Kang Young Lee, Nam Kyu Kim, Hyun Cheol Chung
      Journal of Cancer Research and Clinical Oncology.2016; 142(9): 2051.     CrossRef
    • Is a Preoperative Gastrointestinal Endoscopy for Second Primary Cancer Detection in Head and Neck Cancer Necessary? Ten-year Registry Data
      Gyeong Mi Heo, Mi Hee Kim, Jin Hwan Kim, Young Soo Rho, Woon Geon Shin
      The Korean Journal of Gastroenterology.2016; 68(1): 23.     CrossRef
    • Risk of Cardiovascular Disease Using Framingham Risk Score in Korean Cancer Survivors
      Ji-Hyun So, Jung-Kwon Lee, Jin-Young Shin, Wan Park
      Korean Journal of Family Medicine.2016; 37(4): 235.     CrossRef
    • Factors Associated with Depression Assessed by the Patient Health Questionnaire-2 in Long-Term Cancer Survivors
      Ae-Jin Goo, Yun-Mi Song, Jinyoung Shin, Hyeonyoung Ko
      Korean Journal of Family Medicine.2016; 37(4): 228.     CrossRef
    • How to Improve the Quality of Screening Endoscopy in Korea: National Endoscopy Quality Improvement Program
      Yu Kyung Cho
      Clinical Endoscopy.2016; 49(4): 312.     CrossRef
    • Gastric cancer from operating theatre to bench in Korea
      H-K Yang
      British Journal of Surgery.2016; 103(10): 1251.     CrossRef
    • Current Perspectives on Gastric Cancer
      Juan M. Marqués-Lespier, María González-Pons, Marcia Cruz-Correa
      Gastroenterology Clinics of North America.2016; 45(3): 413.     CrossRef
    • Chronic Myeloid Leukemia Following Radioactive Iodine Treatment for Thyroid Cancer: Two Case Reports and a Literature Review
      Hae Yeul Park, Sung-eun Choi, Young Hoon Ryu, Hang Seok Change, Cheong Soo Park, Kyoung Hwa Lee, Yu Ri Kim
      The Korean Journal of Medicine.2016; 91(1): 70.     CrossRef
    • Comparisons of clinicopathologic factors and survival rates between laparoscopic and open gastrectomy in gastric cancer
      Dong Jun Kim, Sang Hyuk Seo, Kwang Hee Kim, Yo-Han Park, Min Sung An, Ki Beom Bae, Chang Soo Choi, Sang Hoon Oh
      International Journal of Surgery.2016; 34: 161.     CrossRef
    • Solitary bone and brain metastasis in a patient with papillary thyroid carcinoma mimicking cavernous angioma
      Eugene Han, Ye Yeon Lee, El Kim, Sun Young Kwon, Sang Pyo Kim, Hye Soon Kim, Mi Kyung Kim
      The Korean Journal of Internal Medicine.2016; 31(5): 991.     CrossRef
    • Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?
      Soo-Ho Chung
      Journal of Menopausal Medicine.2016; 22(2): 65.     CrossRef
    • SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma
      Hye Seung Lee, Wonkyung Jung, Eunjung Lee, Hyeyoon Chang, Jin Hyuk Choi, Han Gyeom Kim, Aeree Kim, Baek-hui Kim
      Journal of Pathology and Translational Medicine.2016; 50(5): 337.     CrossRef
    • Association between Socioeconomic Status and Cancer Screening in Koreans over 40 Years in Age Based on the 2010–2012 Korean National Health and Nutrition Examination Survey
      Jin-Young Kim, Hee-Taik Kang
      Korean Journal of Family Medicine.2016; 37(5): 287.     CrossRef
    • Polycyclic aromatic hydrocarbon emissions of non-road diesel engine treated with non-thermal plasma technology
      Jianbing Gao, Chaochen Ma, Shikai Xing, Liwei Sun, Jiangquan Liu
      Korean Journal of Chemical Engineering.2016; 33(12): 3425.     CrossRef
    • Return-to-Work Experiences among Nurses after Receiving Cancer Treatment
      Mi-Hye Kim, Jeong-Seon Kim, Han-Na Kim
      Journal of the Korea Academia-Industrial cooperation Society.2016; 17(6): 215.     CrossRef
    • Systematic Review of Trends in the Incidence Rates of Thyroid Cancer
      Joseph J. Wiltshire, Thomas M. Drake, Lesley Uttley, Sabapathy P. Balasubramanian
      Thyroid.2016; 26(11): 1541.     CrossRef
    • Comparison of survival of surgical resection and conservative treatment in patients with gastric cancer aged 80 years or older: a single-center experience
      Chung-Sik Gong, Jeong-Hwan Yook, Sung-Tae Oh, Byung-Sik Kim
      Annals of Surgical Treatment and Research.2016; 91(5): 219.     CrossRef
    • Development of a FFQ for breast cancer survivors in Korea
      Woo-kyoung Shin, Sihan Song, Eunkyung Hwang, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
      British Journal of Nutrition.2016; 116(10): 1781.     CrossRef
    • Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection
      Min Jung Kim, Sang Jin Kim, Sung-Chan Park, Dae Yong Kim, Ji Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Heung Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Jung Nam Joo, Jae Hwan Oh
      Medicine.2016; 95(47): e4925.     CrossRef
    • Does the interval of screening endoscopy affect survival in gastric cancer patients?
      Jieun Kim, Su Mi Kim, Man Ho Ha, Jeong Eun Seo, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Sin-Ho Jung, Jae Moon Bae
      Medicine.2016; 95(49): e5490.     CrossRef
    • Prevalence of Insomnia among Patients with the Ten Most Common Cancers in South Korea: Health Insurance Review and Assessment Service-National Patient Sample
      Boram Park, Soyoung Youn, Chi-Won Christine Hann, Kikyung Yi, Suyeon Lee, Jung-Sun Lee, Seockhoon Chung
      Sleep Medicine Research.2016; 7(2): 48.     CrossRef
    • Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer
      Hye rim Ha, Do-Youn Oh, Tae-Yong Kim, KyoungBun Lee, Kyubo Kim, Kyung-Hun Lee, Sae-Won Han, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Yung-Jue Bang, John Souglakos
      PLOS ONE.2016; 11(3): e0151406.     CrossRef
    • Converged Study on the Nurses' Knowledge and Performance of Cancer Pain Management in one city
      Kyoung Hee Jang, In Sook Jung
      Journal of the Korea Convergence Society.2016; 7(6): 115.     CrossRef
    • Metastatic prostate cancer initially presenting as chylothorax: A case report
      YU-JIN YANG, MINJUNG SEO, HEE-JEONG JEON, JIN-HEE NOH, SEOL HOON PARK, YUNSUK CHOI, JAE-CHEOL JO, JIN HO BAEK, SU-JIN KOH, HAWK KIM, YOUNG JOO MIN
      Molecular and Clinical Oncology.2016; 4(6): 1009.     CrossRef
    • Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer
      HYE YOUN SUNG, JIHYE HAN, WOONG JU, JUNG-HYUCK AHN
      Oncology Reports.2016; 36(1): 535.     CrossRef
    • Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells
      MIN-HO HAN, WON SUP LEE, ARULKUMAR NAGAPPAN, HYE JUNG KIM, CHEOL PARK, GI-YOUNG KIM, SANG HOON HONG, NAM DEUK KIM, GONSUP KIM, CHUNG HO RYU, SUNG CHUL SHIN, YUNG HYUN CHOI
      Oncology Reports.2016; 36(1): 99.     CrossRef
    • Occult gastric cancer with distant metastasis proven by random gastric biopsy
      Sang Hyuk Lee, Kyu-Hyoung Lim, Seo-Young Song, Hui-Young Lee, Sung Chul Park, Chang Don Kang, Sung Joon Lee, Dong Wook Choi, Sung Bae Park, Young-Joon Ryu
      World Journal of Gastroenterology.2016; 22(16): 4270.     CrossRef
    • Synchronous and Metachronous Colon Cancers in Patients with Gastric Cancer: Report of 2 Cases
      Byoung Jo Suh
      Case Reports in Oncology.2016; 9(3): 752.     CrossRef
    • Impact of Perceived Cancer Risk on the Cancer Screening Rate in the General Korean Population: Results from the Korean Health Panel Survey Data
      Jae-Hyun Kim, Eun-Cheol Park, Ki-Bong Yoo
      Asian Pacific Journal of Cancer Prevention.2015; 15(23): 10525.     CrossRef
    • Transenteral Bowel Preparation for Colonoscopy Is More Comfortable than the Traditional Method with No Inferiority in Efficacy
      Sung-Won Jung, Da Hye Jung, Young Chul Shin, In Ho Moh, Hana Yoo, Sung Il Jang, Su Rin Shin, Jin Bae Kim, Sang Hoon Park, Myung Seok Lee
      Digestive Diseases and Sciences.2015; 60(1): 54.     CrossRef
    • Cytochrome P450 1 family and cancers
      Ryeo-Eun Go, Kyung-A Hwang, Kyung-Chul Choi
      The Journal of Steroid Biochemistry and Molecular Biology.2015; 147: 24.     CrossRef
    • Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects
      Hyun-Gyu Choi, Ji-Young Jeon, Yong-Jin Im, Yunjeong Kim, Eun-Kee Song, Young-Hwan Seo, Seok-Je Cho, Min-Gul Kim
      Clinical Drug Investigation.2015; 35(1): 31.     CrossRef
    • Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea
      K S Choi, J K Jun, M Suh, B Park, D K Noh, S H Song, K W Jung, H-Y Lee, I J Choi, E-C Park
      British Journal of Cancer.2015; 112(3): 608.     CrossRef
    • Incidence of cancer in children aged 0–14 years in Taiwan, 1996–2010
      Yen-Lin Liu, Wei-Cheng Lo, Chun-Ju Chiang, Ya-Wen Yang, Meng-Yao Lu, Wen-Ming Hsu, Wan-Ling Ho, Meng-Ju Li, James S. Miser, Dong-Tsamn Lin, Mei-Shu Lai
      Cancer Epidemiology.2015; 39(1): 21.     CrossRef
    • RPM peptide conjugated bioreducible polyethylenimine targeting invasive colon cancer
      Yeong Mi Lee, Duhwan Lee, Jihoon Kim, Hansoo Park, Won Jong Kim
      Journal of Controlled Release.2015; 205: 172.     CrossRef
    • Intraoperatively Assessed Macroscopic Serosal Changes in Patients with Curatively Resected Advanced Gastric Cancer: Clinical Implications for Prognosis and Peritoneal Recurrence
      Changhoon Yoo, Min-Hee Ryu, Young Soo Park, Moon-Won Yoo, Sook Ryun Park, Baek-Yeol Ryoo, Se Jin Jang, Jeong Hwan Yook, Byung Sik Kim, Yoon-Koo Kang
      Annals of Surgical Oncology.2015; 22(9): 2940.     CrossRef
    • Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
      Min-Hee Ryu, Changhoon Yoo, Jong Gwang Kim, Baek-Yeol Ryoo, Young Soo Park, Sook Ryun Park, Hye-Suk Han, Ik Joo Chung, Eun-Kee Song, Kyung Hee Lee, Seok Yun Kang, Yoon-Koo Kang
      European Journal of Cancer.2015; 51(4): 482.     CrossRef
    • Renal cryoablation of small renal masses: A Korea University experience
      Hyung Keun Kim, Jong Hyun Pyun, Jae Yoon Kim, Seung Bin Kim, Seok Cho, Sung Gu Kang, Jeong Gu Lee, Je Jong Kim, Jun Cheon, Seok Ho Kang
      Korean Journal of Urology.2015; 56(2): 117.     CrossRef
    • Effects of oriental medicine music therapy in an ovarian cancer patient with So-Eum-type constitution: a case report
      Seung-Hyun Lee, Eunhye Song, Seul-Ki Kim
      Integrative Medicine Research.2015; 4(1): 48.     CrossRef
    • Survival outcome in endometrial cancer patients according to hereditary predisposition
      Heon Jong Yoo, Myong Cheol Lim, Yedong Son, Sang-Soo Seo, Sokbom Kang, Sun Ho Kim, Chong Woo Yoo, Sang-Yoon Park
      Taiwanese Journal of Obstetrics and Gynecology.2015; 54(1): 24.     CrossRef
    • Ultimate eradication rate of Helicobacter pylori after first, second, or third‐line therapy in Korea
      Kichul Yoon, Nayoung Kim, Ryoung H Nam, Ji H Suh, Seonmin Lee, Jung M Kim, Ju Y Lee, Yong H Kwon, Yoon J Choi, Hyuk Yoon, Cheol M Shin, Young S Park, Dong H Lee
      Journal of Gastroenterology and Hepatology.2015; 30(3): 490.     CrossRef
    • Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates
      Allen S. Ho, Louise Davies, Iain J. Nixon, Frank L. Palmer, Laura Y. Wang, Snehal G. Patel, Ian Ganly, Richard J. Wong, R. Michael Tuttle, Luc G. T. Morris
      Cancer.2015; 121(11): 1793.     CrossRef
    • Gastric Cancer Screening Uptake Trends in Korea
      Sangeun Lee, Jae Kwan Jun, Mina Suh, Boyoung Park, Dai Keun Noh, Kyu-Won Jung, Kui Son Choi
      Medicine.2015; 94(8): e533.     CrossRef
    • Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors
      Jin-Soo Kim, Su-Chan Lee, Hye-Young Min, Kwan Hee Park, Seung Yeob Hyun, So Jung Kwon, Sun Phil Choi, Woo-Young Kim, Hyo-Jong Lee, Ho-Young Lee
      Cancer Letters.2015; 361(2): 197.     CrossRef
    • Imaging Surveillance of Patients with Breast Cancer after Primary Treatment: Current Recommendations
      Jung Hyun Yoon, Min Jung Kim, Eun-Kyung Kim, Hee Jung Moon
      Korean Journal of Radiology.2015; 16(2): 219.     CrossRef
    • Prevalence and Characteristics of Chemotherapy-related Cognitive Impairment in Patients with Breast Cancer
      Jin-Hee Park, Sun Hyoung Bae, Yong-Sik Jung, Young-Mi Jung
      Journal of Korean Academy of Nursing.2015; 45(1): 118.     CrossRef
    • Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients
      Yong Joon Suh, Hyungju Kwon, Su-jin Kim, June Young Choi, Kyu Eun Lee, Young Joo Park, Do Joon Park, Yeo-Kyu Youn
      Annals of Surgical Oncology.2015; 22(11): 3543.     CrossRef
    • Current status of randomized controlled trials for laparoscopic gastric surgery for gastric cancer in Korea
      Cheulsu Byun, Sang‐Uk Han
      Asian Journal of Endoscopic Surgery.2015; 8(2): 130.     CrossRef
    • Treatment for unresectable gastric cancer
      Tae-Yong Kim, Do-Youn Oh, Yung-Jue Bang
      Journal of the Korean Medical Association.2015; 58(3): 209.     CrossRef
    • Management of cancer survivors in Korea
      Dong Wook Shin, Sung Sunwoo, Jungkwon Lee
      Journal of the Korean Medical Association.2015; 58(3): 216.     CrossRef
    • Diagnostic Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology of Pancreatic Lesions
      Hae Woon Baek, Min Jee Park, Ye-Young Rhee, Kyoung Bun Lee, Min A Kim, In Ae Park
      Journal of Pathology and Translational Medicine.2015; 49(1): 52.     CrossRef
    • Feasibility of terahertz reflectometry for discrimination of human early gastric cancers
      Young Bin Ji, Chan Hyuk Park, Hyunki Kim, Sang-Hoon Kim, Gyu Min Lee, Sam Kyu Noh, Tae-In Jeon, Joo-Hiuk Son, Yong-Min Huh, Seungjoo Haam, Seung Jae Oh, Sang Kil Lee, Jin-Suck Suh
      Biomedical Optics Express.2015; 6(4): 1398.     CrossRef
    • Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer
      Jeong Il Yu, Doo Ho Choi, Seung Jae Huh, Won Park, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Won Ho Kil, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park
      Journal of Breast Cancer.2015; 18(1): 50.     CrossRef
    • Pain Control, Nutritional and Emotional Support
      Dong Hee Koh
      Korean Journal of Pancreas and Biliary Tract.2015; 20(1): 22.     CrossRef
    • A Comparison of Outcomes of Three Reconstruction Methods after Laparoscopic Distal Gastrectomy
      Chang Hyun Kim, Kyo Young Song, Cho Hyun Park, Young Joo Seo, Seung-Man Park, Jin-Jo Kim
      Journal of Gastric Cancer.2015; 15(1): 46.     CrossRef
    • A Rare Case of Primary Thymic Adenocarcinoma Mimicking Small Cell Lung Cancer
      Eun Na Cho, Hye Sung Park, Tae Hoon Kim, Min Kwang Byun, Hyung Jung Kim, Chul Min Ahn, Yoon Soo Chang
      Tuberculosis and Respiratory Diseases.2015; 78(2): 112.     CrossRef
    • Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
      Yong-Hyub Kim, Sang-Yun Song, Hyun-Jeong Shim, Woong-Ki Chung, Sung-Ja Ahn, Mee Sun Yoon, Jae-Uk Jeong, Ju-Young Song, Taek-Keun Nam
      Radiation Oncology Journal.2015; 33(1): 12.     CrossRef
    • Sex Differences Associated With Hepatitis B Virus Surface Antigen Seropositivity Unwareness in Hepatitis B Virus Surface Antigen-positive Adults: 2007‐2012 Korea National Health and Nutrition Examination Survey
      Suk-Yong Jang, Sung-In Jang, Hong-Chul Bae, Jaeyong Shin, Eun-Cheol Park
      Journal of Preventive Medicine and Public Health.2015; 48(2): 74.     CrossRef
    • A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
      Jin Won Kim, In Sil Choi, Yu Jung Kim, Kyung-Hun Lee, Keun-Wook Lee, Tae-Yong Kim, Sae-Won Han, Jee Hyun Kim, Tae-You Kim, Jong Seok Lee, Yung-Jue Bang, Seock-Ah Im, Do-Youn Oh
      Cancer Chemotherapy and Pharmacology.2015; 75(6): 1175.     CrossRef
    • The cytotoxic nature of Acanthopanax sessiliflorus stem bark extracts in human breast cancer cells
      Venkatesan Thamizhiniyan, Choi Young-Woong, Kim Young-Kyoon
      Saudi Journal of Biological Sciences.2015; 22(6): 752.     CrossRef
    • Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors
      Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      Gynecologic Oncology.2015; 137(3): 418.     CrossRef
    • Overdiagnosis: epidemiologic concepts and estimation
      Jong-Myon Bae
      Epidemiology and Health.2015; 37: e2015004.     CrossRef
    • Association of Depression and Survival in Patients with Cancer over 10 Years
      Joohyung Kim, Suk Jeong Lee, Jae-Kyung Roh, Sang Jun Shin
      Asian Oncology Nursing.2015; 15(1): 37.     CrossRef
    • The Influence of Stress, Spousal Support, and Resilience on the Ways of Coping among Women with Breast Cancer
      Jiyoung Kang, Eunyoung E. Suh
      Asian Oncology Nursing.2015; 15(1): 1.     CrossRef
    • Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean
      Jong-Myon Bae
      Epidemiology and Health.2015; 37: e2015015.     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012
      Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Chang-Mo Oh, Hyunsoon Cho, Duk Hyoung Lee, Kang Hyun Lee
      Cancer Research and Treatment.2015; 47(2): 127.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2015
      Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Hyunsoon Cho, Duk Hyoung Lee, Kang Hyun Lee
      Cancer Research and Treatment.2015; 47(2): 142.     CrossRef
    • The Korean guideline for thyroid cancer screening
      Ka Hee Yi, Soo Young Kim, Do Hoon Kim, Sun Wook Kim, Dong Gyu Na, You Jin Lee, Ki Wook Chung, Kui Son Choi, Yoon Woo Koh, Won Bae Kim, Kee-Hyun Nam, Seung-Kuk Baek, Jung Hwan Baek, Soon Young Lee, Yuh Seok Jung, Jung Jin Cho, Young-Su Ju, Ji Yeon Dang, Ye
      Journal of the Korean Medical Association.2015; 58(4): 302.     CrossRef
    • Flavonoids from Orostachys Japonicus A. Berger Induces Caspase-dependent Apoptosis at Least Partly through Activation of p38 MAPK Pathway in U937 Human Leukemic Cells
      Won Sup Lee, Jeong Won Yun, Arulkumar Nagappan, Ji Hyun Jung, Sang Mi Yi, Dong Hoon Kim, Hye Jung Kim, GonSup Kim, Chung Ho Ryu, Sung Chul Shin, Soon Chan Hong, Yung Hyun Choi, Jin-Myung Jung
      Asian Pacific Journal of Cancer Prevention.2015; 16(2): 465.     CrossRef
    • The impact of job status on quality of life: general population versus long-term cancer survivors
      Seo Yoon Lee, Sun Jung Kim, Jaeyong Shin, Kyu-Tae Han, Eun-Cheol Park
      Psycho-Oncology.2015; 24(11): 1552.     CrossRef
    • Nationwide epidemiology and healthcare utilization of spine tumor patients in the adult Korean population, 2009–2012
      Seil Sohn, Jinhee Kim, Chun Kee Chung, Na-Rye Lee, Eunjung Park, Ung-Kyu Chang, Moon Jun Sohn, Sung Hwan Kim
      Neuro-Oncology Practice.2015; 2(2): 93.     CrossRef
    • Distribution of the Colonoscopic Adenoma Detection Rate According to Age: Is Recommending Colonoscopy Screening for Koreans Over the Age of 50 Safe?
      Taeseok Bae, Yunhyung Ha, Changkyun Kim, Jihyun Lee, Kwangil Ha, Sanghyun Shin, Youngcheol Lee, Yoonsik Kang
      Annals of Coloproctology.2015; 31(2): 46.     CrossRef
    • Laughter and Stress Relief in Cancer Patients: A Pilot Study
      S. H. Kim, Y. H. Kim, H. J. Kim
      Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
    • Development and application of patient decision aids
      Jong-Myon Bae
      Epidemiology and Health.2015; 37: e2015018.     CrossRef
    • The Association between the Adherence to Dietary Guidelines for Breast Cancer Survivors and Health-related Quality of Life among Korean Breast Cancer Survivors
      Sihan Song, Jiyoung Youn, Myungsook Park, Eunkyung Hwang, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
      Korean Journal of Community Nutrition.2015; 20(2): 129.     CrossRef
    • Multivalent Aptamer/Gold Nanoparticle–Modified Graphene Oxide for Mass Spectrometry–Based Tumor Tissue Imaging
      Rong-Cing Huang, Wei-Jane Chiu, Irving Po-Jung Lai, Chih-Ching Huang
      Scientific Reports.2015;[Epub]     CrossRef
    • The Korean guideline for gastric cancer screening
      Hyun Ah Park, Su Youn Nam, Sang Kil Lee, Sang Gyun Kim, Ki-Nam Shim, Sang Min Park, Sun-Young Lee, Hye Seung Han, Yong Moon Shin, Kyoung-Mee Kim, Kyung-Jae Lee, Tae-Yong Lee, Il Ju Choi, Seong Sook Hong, Jae Woo Kim, Yoon Jae Lee, Soo Young Kim, Yeol Kim,
      Journal of the Korean Medical Association.2015; 58(5): 373.     CrossRef
    • Awareness of cervical cancer prevention among mothers of adolescent daughters in Korea: qualitative research
      Hae Won Kim, Duck Hee Kim
      BMJ Open.2015; 5(5): e006915.     CrossRef
    • Incidence of kidney, bladder, and prostate cancers in Korea: An update
      Wan Song, Hwang Gyun Jeon
      Korean Journal of Urology.2015; 56(6): 422.     CrossRef
    • Trends of liver cancer and its major risk factors in Korea
      Eun-Young Lee, Tran Thi Xuan Mai, Yoonjung Chang, Moran Ki
      Epidemiology and Health.2015; 37: e2015016.     CrossRef
    • The Effect of Gamisoyo-san Intravenous Pharmacopuncture on Restoration of Liver Function after Partial Hepatectomy in SD Rat
      Chan Lee, Jung-Hun Yun, Yun-kyoung Yim
      Journal of Korean Medicine.2015; 36(1): 22.     CrossRef
    • Laparoscopic Surgery for Colorectal Cancer in Korea: Nationwide Data from 2008~2013
      Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
      The Journal of Minimally Invasive Surgery.2015; 18(2): 39.     CrossRef
    • The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database
      Zisun Kim, Sun Young Min, Chan Seok Yoon, Kyu-Won Jung, Beom Seok Ko, Eunyoung Kang, Seok Jin Nam, Seokwon Lee, Min Hee Hur
      Journal of Breast Cancer.2015; 18(2): 103.     CrossRef
    • Development of Job Standards of Clinical Dietitian for the Clinical Nutrition Therapy to Cancer Patients in Hospitals
      Soo-Kyong Choi, Gyung-Ah Wie, Song-Mi Lee, Eun Mi Kim, Mi-Sun Park, Cheongmin Sohn, Mi-Hye Woo, Dal Lae Ju, Jin-A Cha, Jung-Sook Seo
      Journal of the Korean Dietetic Association.2015; 21(2): 91.     CrossRef
    • Factors Influencing Quality of Life in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
      Hyoung-Sook Park, Hyun-Ju Lee, Jae-Hyun Ha
      Journal of Korean Academy of Fundamentals of Nursing.2015; 22(1): 69.     CrossRef
    • Alcohol Drinking, Cigarette Smoking and Risk of Colorectal Cancer in the Korean Multi-center Cancer Cohort
      Sooyoung Cho, Aesun Shin, Sue K. Park, Hai-Rim Shin, Soung-Hoon Chang, Keun-Young Yoo
      Journal of Cancer Prevention.2015; 20(2): 147.     CrossRef
    • Pachymic Acid Induces Apoptosis of EJ Bladder Cancer Cells by DR5 Up-Regulation, ROS Generation, Modulation of Bcl-2 and IAP Family Members
      Jin-Woo Jeong, Won Sup Lee, Se-il Go, Arulkumar Nagappan, Jun Young Baek, Jae-Dong Lee, Su-Jae Lee, Cheol Park, Gi Young Kim, Hye Jung Kim, Gon-Sup Kim, Taeg Kyu Kwon, Chung Ho Ryu, Sung Chul Shin, Yung Hyun Choi
      Phytotherapy Research.2015; 29(10): 1516.     CrossRef
    • Tumour volume changes assessed with high-quality KVCT in lung cancer patients undergoing concurrent chemoradiotherapy
      Y H Lee, Y S Kim, H C Lee, S W Lee, Y N Kang, J H Kang, S H Hong, Y K Kim, S J Kim, M I Ahn, D H Han, I R Yoo, J G Park, S W Sung, K Y Lee
      The British Journal of Radiology.2015; 88(1052): 20150156.     CrossRef
    • Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
      Kyong Yeun Jung, Sun Wook Cho, Young A Kim, Daein Kim, Byung-Chul Oh, Do Joon Park, Young Joo Park
      Journal of Pathology and Translational Medicine.2015; 49(4): 318.     CrossRef
    • Public perception of risk-reducing salpingectomy for preventing ovarian cancer
      Jun Hyeok Kang, Se Hyun Nam, Taejong Song, Woo Young Kim, Kyo Won Lee, Kye Hyun Kim
      Obstetrics & Gynecology Science.2015; 58(4): 284.     CrossRef
    • Association between information provision and decisional conflict in cancer patients
      J.A. Sim, J.S. Shin, S.M. Park, Y.J. Chang, A. Shin, D.Y. Noh, W. Han, H.K. Yang, H.J. Lee, Y.W. Kim, Y.T. Kim, S.Y. Jeong, J.H. Yoon, Y.J. Kim, D.S. Heo, T.Y. Kim, D.Y. Oh, H.G. Wu, H.J. Kim, E.K. Chie, K.W. Kang, Y.H. Yun
      Annals of Oncology.2015; 26(9): 1974.     CrossRef
    • The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
      Dongwoo Kim, Seok-Jun Yoon, Young-Hoon Gong, Young Ae Kim, Hye-Young Seo, Jihyun Yoon, A-Rim Kim
      Journal of Preventive Medicine and Public Health.2015; 48(4): 180.     CrossRef
    • The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer
      Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang, Sung W. Ha
      Journal of Gastrointestinal Surgery.2015; 19(10): 1833.     CrossRef
    • Race and ethnicity considerations in GI endoscopy
      Amy Wang, Aasma Shaukat, Ruben D. Acosta, David H. Bruining, Vinay Chandrasekhara, Krishnavel V. Chathadi, Mohamad A. Eloubeidi, Robert D. Fanelli, Ashley L. Faulx, Lisa Fonkalsrud, Suryakanth R. Gurudu, Loralee R. Kelsey, Mouen A. Khashab, Shivangi Kotha
      Gastrointestinal Endoscopy.2015; 82(4): 593.     CrossRef
    • Impact of alcohol drinking on gastric cancer development according to Helicobacter pylori infection status
      Seung-Hyun Ma, Woohyun Jung, Elisabete Weiderpass, Jieun Jang, Yunji Hwang, Chunghyun Ahn, Kwang-Pil Ko, Soung-Hoon Chang, Hai-Rim Shin, Keun-Young Yoo, Sue K Park
      British Journal of Cancer.2015; 113(9): 1381.     CrossRef
    • Variable Endoscopic Findings and Clinicopathological Characteristics of Borrmann Type 4 Advanced Gastric Cancer
      Ji Young Chang, Ki-Nam Shim, Chung Hyun Tae, A Reum Choe, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Sung-Ae Jung
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2015; 15(3): 166.     CrossRef
    • Qualitative study on experience of health behavior among Korean low-income breast cancer survivors
      Young-Sun Rhee
      Journal of the Korea Academia-Industrial cooperation Society.2015; 16(5): 3188.     CrossRef
    • A Case of Sparganosis that Mimicked Recurrence of Contralateral Breast Cancer
      Seo Ae Han, Byung Woog Kang, Yee Soo Chae, Jun Seok Yoon, Sang Kyung Seo, Ho Young Park, Ji Yeong Park
      The Korean Journal of Medicine.2015; 89(4): 470.     CrossRef
    • Prevalence of Sarcopenia and Its Association with Metabolic Syndrome in Korean Cancer Survivors
      Ji Hyun Moon, Mi Hee Kong, Hyeon Ju Kim
      The Korean Journal of Obesity.2015; 24(3): 140.     CrossRef
    • Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
      Dae-Won Lee, Sae-Won Han, Yongjun Cha, Kyung-Hun Lee, Tae-Yong Kim, Do-Youn Oh, Seock-Ah Im, Yung-Jue Bang, Ji Won Park, Seung-Bum Ryoo, Seung-Yong Jeong, Gyeong Hoon Kang, Kyu Joo Park, Tae-You Kim
      BMC Cancer.2015;[Epub]     CrossRef
    • Ablation of osteopontin suppressesN-methyl-N-nitrosourea andHelicobacter pylori-induced gastric cancer development in mice
      Su-Hyung Lee, Jun-Won Park, Du-Min Go, Hark Kyun Kim, Hyo-Jung Kwon, Sang-Uk Han, Dae-Yong Kim
      Carcinogenesis.2015; : bgv144.     CrossRef
    • Anti-oxidative and Anti-cancer Activities of Treculia africana Extract in Human Colon Adenocarcinoma HT29 Cells
      You Na Oh, Soojung Jin, Hyun-jin Park, Byung Woo Kim, Hyun Ju Kwon
      Journal of Life Science.2015; 25(5): 515.     CrossRef
    • The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea
      Hee Joung Kim, Seung Hun Jang, Jeong-Seon Ryu, Jeong Eun Lee, Young Chul Kim, Min Ki Lee, Tae Won Jang, Shin-Yup Lee, Hidehiro Nakamura, Natsumi Nishikata, Maiko Mori, Yasushi Noguchi, Hiroshi Miyano, Kye Young Lee
      Lung Cancer.2015; 90(3): 522.     CrossRef
    • A qualitative study of women’s views on overdiagnosis and screening for thyroid cancer in Korea
      Sang Hee Park, Bomyee Lee, Sangeun Lee, Eunji Choi, Eun-Bi Choi, Jisu Yoo, Jae Kwan Jun, Kui Son Choi
      BMC Cancer.2015;[Epub]     CrossRef
    • Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?
      Gwang Ha Kim, Sung Jo Bang, Alexander R. Ende, Joo Ha Hwang
      The Korean Journal of Internal Medicine.2015; 30(6): 747.     CrossRef
    • The necessity of an observational study on the interactions between allergic history and citrus fruit intake for the prevention of pancreatic cancer
      Jong-Myon Bae
      Epidemiology and Health.2015; 37: e2015028.     CrossRef
    • Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis
      Jong-Myon Bae
      Epidemiology and Health.2015; 37: e2015005.     CrossRef
    • Changing trends in the incidence (1999-2011) and mortality (1983-2013) of cervical cancer in the Republic of Korea
      Yoon Park, Champadeng Vongdala, Jeongseon Kim, Moran Ki
      Epidemiology and Health.2015; 37: e2015024.     CrossRef
    • Assessing Activity Limitation Among Cancer Survivors in Korea Using Data from a Nationwide Survey
      Myueng Guen Oh, Mi Ah Han, Yu Mi Byeon, Kyung Min Bae, Seong-Hyung Choi
      Asian Pacific Journal of Cancer Prevention.2015; 16(7): 2739.     CrossRef
    • Cost-effectiveness Analysis of Cervical Cancer Screening Strategies Based on the Papanicolaou Smear Test in Korea
      Min Jung Ko, Jimin Kim, Younhee Kim, Yoon Jae Lee, Sung Ran Hong, Jae Kwan Lee
      Asian Pacific Journal of Cancer Prevention.2015; 16(6): 2317.     CrossRef
    • Safety Management Status among Nurses Handling Anticancer Drugs: Nurse Awareness and Performance Following Safety Regulations
      Kyeong Weon Jeong, Bo-Young Lee, Myung Soon Kwon, Ji-Hye Jang
      Asian Pacific Journal of Cancer Prevention.2015; 16(8): 3203.     CrossRef
    • Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012
      Eun-Hye Park, Hyewon Lee, Young-Joo Won, Hee Young Ju, Chang-Mo Oh, Cecile Ingabire, Hyun-Joo Kong, Byung-Kiu Park, Ju Young Yoon, Hyeon-Seok Eom, Eunyoung Lee, Hyeon Jin Park
      Blood Research.2015; 50(4): 204.     CrossRef
    • Lung cancer risk in professional drivers in Korea: A population‐based proportionate cancer incidence ratio study
      Dong‐Hee Koh, Hyun‐Joo Kong, Chang‐Mo Oh, Kyu‐Won Jung, Donguk Park, Young‐Joo Won
      Journal of Occupational Health.2015; 57(4): 324.     CrossRef
    • Factors Affecting Prostate Cancer Screening Behavior
      Eun Nam Lee, Jin Hee Park, Sung Gum Kang, Seonyoung Yun, Kyung Mi Sin, Kyoung Mi Kim
      Asian Oncology Nursing.2015; 15(4): 256.     CrossRef
    • MHY218-induced apoptotic cell death is enhanced by the inhibition of autophagy in AGS human gastric cancer cells
      PYOUNG RAK CHOI, YONG JUNG KANG, BOKYUNG SUNG, JAE HYUN KIM, HYUNG RYONG MOON, HAE YOUNG CHUNG, SUNG EUN KIM, MOO IN PARK, SEUN JA PARK, NAM DEUK KIM
      International Journal of Oncology.2015; 47(2): 563.     CrossRef
    • The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells
      HWANG-BO HYUN, WON SUP LEE, SE-IL GO, ARULKUMAR NAGAPPAN, CHEOL PARK, MIN HO HAN, SU HYUN HONG, GONSUP KIM, GI YOUNG KIM, JAEHUN CHEONG, CHUNG HO RYU, SUNG CHUL SHIN, YUNG HYUN CHOI
      International Journal of Oncology.2015; 46(6): 2670.     CrossRef
    • Poncirin Induces Apoptosis in AGS Human Gastric Cancer Cells through Extrinsic Apoptotic Pathway by up-Regulation of Fas Ligand
      Venu Saralamma, Arulkumar Nagappan, Gyeong Hong, Ho Lee, Silvia Yumnam, Suchismita Raha, Jeong Heo, Sang Lee, Won Lee, Eun Kim, Gon Kim
      International Journal of Molecular Sciences.2015; 16(9): 22676.     CrossRef
    • The Effect of National Cancer Screening on Disparity Reduction in Cancer Stage at Diagnosis by Income Level
      Hye-Min Jung, Jin-Seok Lee, David R. Lairson, Yoon Kim, Bart O. Williams
      PLOS ONE.2015; 10(8): e0136036.     CrossRef
    • Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010)
      Yuh-S Jung, Jiwon Lim, Kyu-Won Jung, Junsun Ryu, Young-Joo Won, Jeffrey S Chang
      PLOS ONE.2015; 10(7): e0134160.     CrossRef
    • Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study
      Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Hyunsoon Cho, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won, Shian-Ying Sung
      PLOS ONE.2015; 10(10): e0140693.     CrossRef
    • Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
      Yung-Jue Bang, Seock-Ah Im, Keun-Wook Lee, Jae Yong Cho, Eun-Kee Song, Kyung Hee Lee, Yeul Hong Kim, Joon Oh Park, Hoo Geun Chun, Dae Young Zang, Anitra Fielding, Jacqui Rowbottom, Darren Hodgson, Mark J. O'Connor, Xiaolu Yin, Woo Ho Kim
      Journal of Clinical Oncology.2015; 33(33): 3858.     CrossRef
    • Relationship between Cancer Worry and Stages of Adoption for Breast Cancer Screening among Korean Women
      Eunji Choi, Yoon Young Lee, Hyo Joong Yoon, Sangeun Lee, Mina Suh, Boyoung Park, Jae Kwan Jun, Yeol Kim, Kui Son Choi, Ali Montazeri
      PLOS ONE.2015; 10(7): e0132351.     CrossRef
    • Diagnostic Value of Osteopontin in Ovarian Cancer: A Meta-Analysis and Systematic Review
      Zhi-De Hu, Ting-Ting Wei, Min Yang, Ning Ma, Qing-Qin Tang, Bao-Dong Qin, Hai-Tao Fu, Ren-Qian Zhong, Gianpaolo Papaccio
      PLOS ONE.2015; 10(5): e0126444.     CrossRef
    • Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients
      Anna Song
      World Journal of Gastroenterology.2015; 21(43): 12410.     CrossRef
    • Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
      Jeong Mo Bae
      World Journal of Gastroenterology.2015; 21(5): 1457.     CrossRef
    • Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea
      Suk Pyo Shin
      World Journal of Gastroenterology.2015; 21(46): 13064.     CrossRef
    • Companion diagnostics for the targeted therapy of gastric cancer
      Changhoon Yoo
      World Journal of Gastroenterology.2015; 21(39): 10948.     CrossRef
    • NKX6.3 controls gastric differentiation and tumorigenesis
      Jung Hwan Yoon, Won Suk Choi, Olga Kim, Sung Sook Choi, Eun Kyung Lee, Suk Woo Nam, Jung Young Lee, Won Sang Park
      Oncotarget.2015; 6(29): 28425.     CrossRef
    • Pediatric Patients With Multifocal Papillary Thyroid Cancer Have Higher Recurrence Rates Than Adult Patients: A Retrospective Analysis of a Large Pediatric Thyroid Cancer Cohort Over 33 Years
      Young Ah Lee, Hae Woon Jung, Hwa Young Kim, Hoonsung Choi, Hyun-Young Kim, J. Hun Hah, Do Joon Park, June-Key Chung, Sei Won Yang, Choong Ho Shin, Young Joo Park
      The Journal of Clinical Endocrinology & Metabolism.2015; 100(4): 1619.     CrossRef
    • Clinical Application of Genetics in Management of Colorectal Cancer
      Eun Ran Kim, Young-Ho Kim
      Intestinal Research.2014; 12(3): 184.     CrossRef
    • Non-surgical treatment versus radical esophagectomy for clinical T1N0M0 esophageal carcinoma: a single-center experience
      Inkeun Park, Yong-Hee Kim, Dok Hyun Yoon, Sook Ryun Park, Hyeong Ryul Kim, Jong Hoon Kim, Hwoon-Yong Jung, Gin Hyug Lee, Kyung-Ja Cho, Sung-Bae Kim
      Cancer Chemotherapy and Pharmacology.2014; 74(5): 995.     CrossRef
    • Health promotion and disease prevention in the older adults
      Chang Won Won
      Journal of the Korean Medical Association.2014; 57(9): 756.     CrossRef
    • Methodological issues for determining intervals of subsequent cancer screening
      Jong-Myon Bae
      Epidemiology and Health.2014; 36: e2014010.     CrossRef
    • Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery
      Min-Hyun Baek, Jeong-Yeol Park, Daeyeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam
      Gynecologic Oncology.2014; 135(3): 462.     CrossRef
    • Two Hypotheses of Dense Breasts and Viral Infection for explaining incidence rates of breast cancer by age group in Korean women
      Jong-Myon Bae
      Epidemiology and Health.2014; : e2014020.     CrossRef
    • Serum prostate-specific antigen levels and type of work in tire manufacturing workers
      Soo-Hyeon Kim, Keun-Ho Jang, Won-Ju Park, Do-Hyeong Kwon, Won-Yang Kang, Hyeong-Min Lim, Jai-Dong Moon
      Annals of Occupational and Environmental Medicine.2014;[Epub]     CrossRef
    • Chemotherapy for Advanced Gastric Cancer in Elderly Patients
      Mi-Jung Kim, Sook Ryun Park
      Korean Journal of Medicine.2014; 87(5): 521.     CrossRef
    • Overdiagnosis and screening for thyroid cancer in Korea
      Jae-Ho Lee, Sang Won Shin
      The Lancet.2014; 384(9957): 1848.     CrossRef
    • A prospective cohort study on postoperative radiotherapy with TomoDirect using simultaneous integrated boost technique in early breast cancer
      Hyo Chun Lee, Sung Hwan Kim, Young Jin Suh, Mi Joo Chung, Dae Gyu Kang, Hyun Joo Choi, Jong Hoon Lee
      Radiation Oncology.2014;[Epub]     CrossRef
    • Difference in Adenoma Detection Rates according to Colonoscopic Withdrawal Times and the Level of Expertise
      Young Doo Kim, Won Ki Bae, Yun Ho Choi, Yoon Jung Jwa, Sang Kyung Jung, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Nam-Hoon Kim, Kyung-Ah Kim, June Sung Lee
      The Korean Journal of Gastroenterology.2014; 64(5): 278.     CrossRef
    • Prevention Strategies for Gastric Cancer: A Global Perspective
      Jin Young Park, Lawrence von Karsa, Rolando Herrero
      Clinical Endoscopy.2014; 47(6): 478.     CrossRef
    • Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups
      Il Ju Choi
      Clinical Endoscopy.2014; 47(6): 497.     CrossRef
    • Distribution of Dense Breasts using Screening Mammography in Korean Women: a Retrospecitive Observational Study
      Jong-Myon Bae, Sang Yop Shin, Eun Hee Kim, Yoon-Nma Kim, Chung Mo Nam
      Epidemiology and Health.2014; : e2014027.     CrossRef
    • WITHDRAWN: Prostate cancer in Asia: A collaborative report
      Rui Chen, Shancheng Ren, Ming Kwong Yiu, Ng Chi Fai, Wai Sam Cheng, Lap Hong Ian, Seiji Naito, Tadashi Matsuda, Elijah Kehinde, Ali Kural, Jason Yichun Chiu, Rainy Umbas, Qiang Wei, Xiaolei Shi, Liqun Zhou, Jian Huang, Yiran Huang, Liping Xie, Lulin Ma, C
      Asian Journal of Urology.2014;[Epub]     CrossRef
    • Current Status and Future Prospect of Robotic Surgery in Korea
      Nak Song Sung, Seon-Hahn Kim
      The Journal of Minimally Invasive Surgery.2014; 17(4): 55.     CrossRef
    • Suggestions for establishing a sustainable risk communication platform for carcinogenic factors
      Keeho Park, Yong-Chan Kim, Youngho Kim, Meeyoung Cha, Woon Heui Han, Dae-Kyu Oh
      Epidemiology and Health.2014; : e2014034.     CrossRef
    • Quality Improvement of Gastrointestinal Endoscopy in Korea: Past, Present, and Future
      Jae Myung Cha
      The Korean Journal of Gastroenterology.2014; 64(6): 320.     CrossRef
    • Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
      Yun Mi Choi, Tae Yong Kim, Eun Kyung Jang, Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Young Kee Shong, Won Bae Kim
      Endocrinology and Metabolism.2014; 29(4): 530.     CrossRef
    • Oral signs of acute leukemia for early detection
      Hyun-Chang Lim, Chang-Sung Kim
      Journal of Periodontal & Implant Science.2014; 44(6): 293.     CrossRef
    • Comparison of Compliance of Adjuvant Chemotherapy Between Laparoscopic and Open Surgery in Patients With Colon Cancer
      Kan Ho Chun, Byung Noe Bae, Hoon An, Hyeonseok Jeong, Hyunjin Cho, Geumhee Gwak, Keun Ho Yang, Ki Hwan Kim, Hong Ju Kim, Young Duk Kim
      Annals of Coloproctology.2014; 30(6): 274.     CrossRef
    • Uncut Roux-en-Y Reconstruction after Laparoscopic Distal Gastrectomy Can Be a Favorable Method in Terms of Gastritis, Bile Reflux, and Gastric Residue
      Ji Yeon Park, Yong Jin Kim
      Journal of Gastric Cancer.2014; 14(4): 229.     CrossRef
    • Nursing Needs and Burden of Family Caregivers of Middle-Aged Hepatocellular Carcinoma Patients
      Yu Jin Lee, Hyunwook Kang
      Asian Oncology Nursing.2014; 14(4): 227.     CrossRef
    • Factors Associated with Intention to receive Human Papillomavirus Vaccine in Undergraduate Women: An Application of the Theory of Planned Behavior
      Kyu Eun Lee
      Journal of Korean Academy of Fundamentals of Nursing.2014; 21(4): 457.     CrossRef
    • Knowledge, Attitude, and Preventive Health Behavior of Cancer in Middle-aged Men
      Youngrye Park, Hwee Wee
      The Korean Journal of Rehabilitation Nursing.2014; 17(2): 97.     CrossRef
    • Diet and Cancer Risk in the Korean Population: A Meta-analysis
      Hae Dong Woo, Sohee Park, Kyungwon Oh, Hyun Ja Kim, Hae Rim Shin, Hyun Kyung Moon, Jeongseon Kim
      Asian Pacific Journal of Cancer Prevention.2014; 15(19): 8509.     CrossRef
    • Cervical Cancer Trends in Mexico: Incidence, Mortality and Research Output
      Maricruz Anaya-Ruiz, Ana Karen Vincent, Martin Perez-Santos
      Asian Pacific Journal of Cancer Prevention.2014; 15(20): 8689.     CrossRef
    • Prostate cancer in Asia: A collaborative report
      Rui Chen, Shancheng Ren, Ming Kwong Yiu, Ng Chi Fai, Wai Sam Cheng, Lap Hong Ian, Seiji Naito, Tadashi Matsuda, Elijah Kehinde, Ali Kural, Jason Yichun Chiu, Rainy Umbas, Qiang Wei, Xiaolei Shi, Liqun Zhou, Jian Huang, Yiran Huang, Liping Xie, Lulin Ma, C
      Asian Journal of Urology.2014; 1(1): 15.     CrossRef
    • Creating of Standard Operating Procedures for Chronic Inhlation and Carcinogenicity Test
      Kyung-Taek Rim, Soo-Jin Kim
      Journal of Korean Society of Occupational and Environmental Hygiene.2014; 24(4): 578.     CrossRef
    • Selection of Candidate Materials and their Prioritization for Chronic Inhalation and Carcinogenicity Test
      Kyung-Taek Rim, Cheol-Hong Lim, Byung-Joon Ahn
      Journal of Korean Society of Occupational and Environmental Hygiene.2014; 24(4): 587.     CrossRef
    • Risk of Cancer Mortality according to the Metabolic Health Status and Degree of Obesity
      Chang-Mo Oh, Jae Kwan Jun, Mina Suh
      Asian Pacific Journal of Cancer Prevention.2014; 15(22): 10027.     CrossRef
    • Improving Accuracy and Completeness in the Collaborative Staging System for Stomach Cancer in South Korea
      Hyun-Sook Lim, Young-Joo Won, Yoo-Kyung Boo
      Asian Pacific Journal of Cancer Prevention.2014; 15(21): 9529.     CrossRef
    • Time Trends Analysis of Characteristics of Patients with Thyroid Cancer in a Single Medical Center
      Hyung Seo Jung, Min Ji Jeon, Dong Eun Song, Suck Joon Hong, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Won Bae Kim
      Journal of Korean Thyroid Association.2014; 7(2): 159.     CrossRef
    • Oral Contraceptive Use and Breast Cancer in Korean Women
      Bo-Ram Choi, Moon-Hee Kwon, Mi-Ran Bang
      The Korean Journal of Health Service Management.2014; 8(4): 221.     CrossRef
    • Effect of Nerve-Sparing Radical Prostatectomy on Urinary Continence in Patients With Preoperative Erectile Dysfunction
      Yong Hyun Park, Oh Seong Kwon, Sung-Hoo Hong, Sae Woong Kim, Tae-Kon Hwang, Ji Youl Lee
      International Neurourology Journal.2006; 20(1): 69.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011
      Cancer Res Treat. 2014;46(2):109-123.   Published online April 15, 2014
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    • 3
    • 4
    • 5
    Related articles
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011
    Image Image Image Image Image Image
    Fig. 1 Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2011 in Korea. Age standardization was based on the world standard population.
    Fig. 2 Trends in age-standardized incidences of selected cancers by sex from 1999 to 2011 in Korea. Age standardization was based on the world standard population. (A) Male. (B) Female.
    Fig. 3 Age-specific incidence rates of major cancers for 2011 in Korea. (A) Male. (B) Female.
    Fig. 4 Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2011 in Korea. Age standardization was based on the world standard population. (A) Male. (B) Female.
    Fig. 5 Trends in relative survival by year of diagnosis from 1999 to 2011. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
    Fig. 6 Prevalence of major cancer sites by time since diagnosis on January 1, 2012 in Korea.
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011
    Site/Type New cases Deaths Prevalent casesa)



    Both Male Female Both Male Female Both Male Female
    All sites 218,017 110,151 107,866 71,579 44,860 26,719 1,097,253 491,505 605,748
    Lip, oral cavity, and pharynx 2,876 2,102 774 940 727 213 15,525 10,517 5,008
    Esophagus 2,245 2,053 192 1,507 1,368 139 6,813 6,157 656
    Stomach 31,637 21,344 10,293 9,719 6,321 3,398 188,995 125,526 63,469
    Colon and rectum 28,112 17,157 10,955 7,660 4,351 3,309 154,816 92,236 62,580
    Liver 16,463 12,189 4,274 10,946 8,226 2,720 47,698 35,689 12,009
    Gallbladderb) 4,993 2,479 2,514 3,701 1,825 1,876 13,531 6,895 6,636
    Pancreas 5,080 2,807 2,273 4,379 2,394 1,985 6,379 3,504 2,875
    Larynx 1,108 1,042 66 387 354 33 8,143 7,651 492
    Lung 21,753 15,167 6,586 15,867 11,503 4,364 48,795 31,857 16,938
    Breast 16,015 73 15,942 2,018 19 1,999 117,652 523 117,129
    Cervix uteri 3,728 - 3,728 989 - 989 41,077 - 41,077
    Corpus uteri 1,921 - 1,921 217 - 217 13,563 - 13,563
    Ovary 2,010 - 2,010 901 - 901 12,918 - 12,918
    Prostate 8,952 8,952 - 1,403 1,403 0 42,157 42,157 -
    Testis 226 226 - 20 20 0 1,979 1,979 -
    Kidney 3,989 2,722 1,267 834 583 251 23,076 15,549 7,527
    Bladder 3,549 2,847 702 1,169 853 316 23,779 19,358 4,421
    Brain and CNS 1,592 847 745 1,214 663 551 8,013 4,160 3,853
    Thyroid 40,568 7,006 33,562 389 116 273 215,178 33,112 182,066
    Hodgkin lymphoma 259 163 96 49 36 13 1,812 1,154 658
    Non-Hodgkin lymphoma 4,367 2,396 1,971 1,389 809 580 23,627 12,837 10,790
    Multiple myeloma 1,050 589 461 661 357 304 3,431 1,842 1,589
    Leukemia 2,862 1,598 1,264 1,557 904 653 13,672 7,527 6,145
    Other and ill-defined 12,662 6,392 6,270 3,663 2,028 1,635 64,624 31,275 33,349
    Site/Type Crude incidence rate per 100,000 Age-standardized incidence rate per 100,000a)


    Both Male Female Both Male Female
    All sites 435.1 439.2 431.0 299.8 332.9 286.2
    Lip, oral cavity, and pharynx 5.7 8.4 3.1 4.0 6.3 2.1
    Esophagus 4.5 8.2 0.8 3.0 6.2 0.4
    Stomach 63.1 85.1 41.1 42.5 63.3 25.1
    Colon and rectum 56.1 68.4 43.8 37.8 51.4 26.4
    Liver 32.9 48.6 17.1 22.2 35.6 10.3
    Gallbladderb) 10.0 9.9 10.0 6.4 7.6 5.5
    Pancreas 10.1 11.2 9.1 6.6 8.5 5.1
    Larynx 2.2 4.2 0.3 1.5 3.1 0.2
    Lung 43.4 60.5 26.3 28.3 46.0 15.1
    Breast 32.0 0.3 63.7 22.2 0.2 43.8
    Cervix uteri 7.4 - 14.9 5.2 - 10.1
    Corpus uteri 3.8 - 7.7 2.7 - 5.3
    Ovary 4.0 - 8.0 2.9 - 5.7
    Prostate 17.9 35.7 - 11.8 27.4 -
    Testis 0.5 0.9 - 0.5 0.9 -
    Kidney 8.0 10.9 5.1 5.6 8.1 3.4
    Bladder 7.1 11.4 2.8 4.6 8.7 1.5
    Brain and CNS 3.2 3.4 3.0 2.7 3.0 2.4
    Thyroid 81.0 27.9 134.1 58.3 20.2 96.8
    Hodgkin lymphoma 0.5 0.6 0.4 0.5 0.6 0.4
    Non-Hodgkin lymphoma 8.7 9.6 7.9 6.5 7.7 5.5
    Multiple myeloma 2.1 2.3 1.8 1.4 1.8 1.1
    Leukemia 5.7 6.4 5.1 5.2 6.1 4.5
    Other and ill-defined 25.3 25.5 25.1 17.8 20.3 15.7
    Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
    All causes 257,396 100.0 331.9
    1 Cancer 71,579 27.8 91.8
    2 Cerebrovascular disease 25,404 9.9 30.3
    3 Heart disease 24,944 9.7 30.5
    4 Intentional self-harm (suicide) 15,906 6.2 23.4
    5 Diabetes mellitus 10,775 4.2 13.0
    6 Pneumonia 8,606 3.3 10.2
    7 Chronic lower respiratory diseases 6,959 2.7 8.0
    8 Disease of liver 6,751 2.6 9.0
    9 Transport accidents 6,316 2.5 9.7
    10 Hypertensive diseases 5,038 2.0 5.9
    Others 75,118 29.2 99.9
    Site/Type Crude mortality rate per 100,000 Age-standardized mortality rate per 100,000a)


    Both Male Female Both Male Female
    All sites 142.8 178.9 106.7 91.8 137.3 59.1
    Lip, oral cavity, and pharynx 1.9 2.9 0.9 1.2 2.2 0.5
    Esophagus 3.0 5.5 0.6 1.9 4.1 0.3
    Stomach 19.4 25.2 13.6 12.3 19.3 7.1
    Colon and rectum 15.3 17.3 13.2 9.6 13.4 6.9
    Liver 21.8 32.8 10.9 14.5 24.3 6.1
    Gallbladderb) 7.4 7.3 7.5 4.6 5.7 3.8
    Pancreas 8.7 9.5 7.9 5.6 7.3 4.2
    Larynx 0.8 1.4 0.1 0.5 1.1 0.1
    Lung 31.7 45.9 17.4 19.8 35.0 9.1
    Breast 4.0 0.1 8.0 2.7 0.1 5.2
    Cervix uteri 2.0 - 4.0 1.3 - 2.3
    Corpus uteri 0.4 - 0.9 0.3 - 0.6
    Ovary 1.8 - 3.6 1.2 - 2.2
    Prostate 2.8 5.6 - 1.6 4.6 -
    Testis 0.0 0.1 - 0.0 0.1 --
    Kidney 1.7 2.3 1.0 1.1 1.8 0.5
    Bladder 2.3 3.4 1.3 1.4 2.7 0.6
    Brain and CNS 2.4 2.6 2.2 1.8 2.2 1.5
    Thyroid 0.8 0.5 1.1 0.5 0.4 0.5
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 2.8 3.2 2.3 1.8 2.5 1.3
    Multiple myeloma 1.3 1.4 1.2 0.9 1.1 0.7
    Leukemia 3.1 3.6 2.6 2.4 3.0 1.8
    Other and ill-defined 7.3 8.1 6.5 4.8 6.3 3.7
    Site/Type Year APC

    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
    All sites 210.5 205.1 216.7 220.1 227.6 234.8 247.7 251.8 262.9 275.2 285.9 291.5 299.8 3.4a)
    Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.8 3.9 4.0 0.4
    Esophagus 4.1 3.7 3.9 3.8 3.6 3.6 3.5 3.4 3.3 3.3 3.1 3.1 3.0 ‒2.2a)
    Stomach 43.6 42.3 44.0 43.6 43.2 41.2 44.4 42.8 41.8 42.5 43.3 42.3 42.5 ‒0.2
    Colon and rectum 20.4 21.0 22.9 24.7 26.8 28.6 30.9 32.4 33.7 34.8 36.8 36.7 37.8 5.6a)
    Liver 27.9 26.7 27.3 26.5 25.7 25.6 25.8 24.6 24.4 24.0 23.5 22.7 22.2 ‒1.8a)
    Gallbladderb) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.6 6.4 6.8 6.6 6.4 ‒0.1
    Pancreas 5.6 5.5 5.5 5.8 5.9 6.0 6.3 6.2 6.3 6.4 6.3 6.4 6.6 -1.5a)
    Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.7 1.7 1.6 1.5 ‒3.6a)
    Lung 28.5 27.7 28.3 28.5 27.9 28.8 29.0 28.7 28.4 28.2 28.2 28.4 28.3 0.0
    Breast 10.7 10.8 12.7 13.9 14.2 15.0 16.3 16.9 18.1 18.9 19.6 20.5 22.2 6.1a)
    Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.7 5.9 5.5 5.6 5.2 ‒4.2a)
    Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 2.4 2.6 2.6 2.7 5.9a)
    Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.1 2.9 2.8 3.0 2.9 1.3a)
    Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.3 8.6 9.8 10.6 11.0 11.8 13.8a)
    Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 4.3a)
    Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.0 5.2 5.3 5.6 6.0a)
    Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.6 4.6 4.6 ‒0.2
    Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.0 3.0 3.0 2.7 0.5
    Thyroid 6.3 6.1 7.9 9.5 12.8 17.2 20.7 25.4 32.8 41.3 48.0 53.5 58.3 23.3a)
    Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.5 4.9a)
    Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 4.9 5.3 5.3 5.5 5.6 5.6 6.1 6.1 6.5 3.5a)
    Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 1.5 1.4 3.6a)
    Leukemia 4.7 4.3 4.7 4.8 4.8 4.8 4.7 4.9 4.8 5.0 5.1 5.0 5.2 1.1a)
    Other and ill-defined 14.3 13.5 13.9 13.5 15.2 15.2 16.2 16.1 17.1 17.0 17.0 17.3 17.8 2.4a)
    Site/Type Year APC

    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
    All sites 285.0 276.7 288.3 290.0 294.8 299.4 311.3 310.0 316.4 323.3 329.8 329.7 332.9 1.6a)
    Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.2 6.1 6.1 6.3 6.5 6.1 6.1 6.3 0.3
    Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 7.0 7.0 6.6 6.5 6.2 ‒2.6a)
    Stomach 66.2 65.0 67.2 66.6 65.9 62.3 66.9 65.4 63.1 64.4 64.9 63.1 63.3 ‒0.4a)
    Colon and rectum 26.2 27.2 29.6 32.9 35.3 37.9 41.1 43.3 45.3 46.9 49.8 49.7 51.4 6.1a)
    Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.2 39.7 39.4 38.1 36.7 35.6 ‒2.1a)
    Gallbladderb) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.1 8.2 7.6 ‒0.2
    Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.4 8.1 8.0 8.5 0.7a)
    Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.8 3.8 3.5 3.6 3.4 3.1 ‒3.7a)
    Lung 51.4 49.8 51.1 51.0 50.0 50.8 50.9 49.2 48.7 47.6 47.4 47.2 46.0 ‒0.8a)
    Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 ‒0.9
    Prostate 8.4 7.2 9.5 10.1 12.4 15.1 15.7 17.9 20.9 23.4 25.1 25.9 27.4 12.3a)
    Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 4.2a)
    Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.1 7.4 7.6 7.9 8.1 5.7a)
    Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.4 9.1 8.7 8.8 8.7 ‒0.4
    Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.1 3.4 3.4 3.4 3.4 3.0 0.6
    Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.3 15.6 18.5 20.2 24.2a)
    Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.6 0.6 3.9a)
    Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.5 6.9 7.0 6.8 7.4 7.3 7.7 2.7a)
    Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.5 1.6 1.7 1.9 1.8 1.8 3.3a)
    Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.6 5.6 5.7 5.8 5.9 6.0 6.1 1.1a)
    Other and ill-defined 17.9 16.5 16.8 16.5 18.5 18.2 19.2 18.8 20.2 19.7 19.9 19.6 20.3 1.7a)
    Site/Type Year APC

    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
    All sites 61.1 157.4 169.0 174.6 184.3 193.4 207.8 16.4 232.0 249.0 263.0 273.6 286.2 5.4a)
    Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 2.2 2.1 1.2
    Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 0.4 0.4 ‒2.6a)
    Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.1 24.8 25.1 25.7 25.2 25.1 ‒0.4
    Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.5 23.0 24.1 24.5 25.1 26.3 26.0 26.4 4.5a)
    Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.4 11.1 11.1 10.7 10.6 10.3 10.3 ‒1.5a)
    Gallbladderb) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.8 5.4 5.5 ‒0.1
    Pancreas 4.0 4.0 4.0 4.2 4.5 4.5 4.7 4.7 4.8 4.9 4.9 5.0 5.1 2.2a)
    Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 ‒7.6a)
    Lung 12.4 12.5 12.3 12.6 12.4 13.0 13.5 14.0 13.9 14.2 14.1 14.6 15.1 1.7a)
    Breast 20.9 20.9 24.7 27.2 27.8 29.3 32.0 33.3 35.6 37.1 38.7 40.4 43.8 6.3a)
    Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.1 12.4 12.2 11.1 11.5 10.6 10.8 10.1 ‒4.0a)
    Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.1 5.1 5.3 6.1a)
    Ovary 5.0 4.8 4.8 5.0 5.1 5.2 5.4 5.4 5.9 5.6 5.4 5.8 5.7 1.6a)
    Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.2 3.0 3.4 6.0a)
    Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.6 1.5 1.5 ‒0.8
    Brain and CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.7 2.9 2.7 2.6 2.7 2.4 0.3
    Thyroid 10.4 10.1 13.2 16.2 21.8 29.5 35.3 43.3 55.6 69.4 80.6 88.6 96.8 23.3a)
    Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.4 6.3a)
    Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.4 4.4 4.4 4.7 5.1 5.1 5.5 4.5a)
    Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.3 1.1 3.9a)
    Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.2 4.3 4.2 4.1 4.5 0.9a)
    Other and ill-defined 11.8 11.5 11.8 11.5 12.8 13.1 13.9 14.1 14.8 14.9 14.8 15.5 15.7 3.0a)
    Rank Age group (yr)

    0-14 15-34 35-64 ≥65
    Male
     1 Leukemia Thyroid Stomach Lung
    (5.0) (12.8) (99.4) (449.8)
     2 Non-Hodgkin lymphoma Colon and rectum Colon and rectum Stomach
    (2.0) (3.3) (78.6) (438.4)
     3 Brain and CNS Leukemia Liver Colon and rectum
    (1.9) (3.2) (66.5) (355.9)
     4 Kidney Non-Hodgkin lymphoma Thyroid Prostate
    (0.5) (3.2) (47.7) (298.1)
     5 Liver Stomach Lung Liver
    (0.3) (3.0) (44.1) (202.1)
    Female
     1 Leukemia Thyroid Thyroid Colon and rectum
    (4.6) (65.1) (234.1) (181.1)
     2 Brain and CNS Breast Breast Stomach
    (1.7) (11.0) (117.8) (157.8)
     3 Non-Hodgkin lymphoma Cervix uteri Stomach Lung
    (1.4) (5.4) (43.8) (129.0)
     4 Ovary Stomach Colon and rectum Thyroid
    (0.8) (3.7) (43.6) (93.6)
     5 Thyroid Ovary Cervix uteri Liver
    (0.8) (3.1) (22.0) (77.4)
    Site/Type Both Male Female



    1993-1995 1996-2000 2001-2005 2007-2011 Changea) 1993-1995 1996-2000 2001-2005 2007-2011 Changea) 1993-1995 1996-2000 2001-2005 2007-2011 Changea)
    All sites 41.2 44.0 53.8 66.3 25.1 31.7 35.3 45.2 57.6 25.9 53.4 55.3 64.0 75.2 21.8
    Lip, oral cavity, and pharynx 41.1 46.7 54.1 61.6 20.5 35.8 41.1 49.3 57.3 21.5 58.1 63.8 67.7 73.2 15.1
    Esophagus 12.7 15.2 21.2 30.2 17.5 11.8 14.3 20.4 29.7 17.9 23.7 24.2 29.5 35.4 11.7
    Stomach 42.8 46.6 57.7 69.4 26.6 43.0 46.9 58.4 70.1 27.1 42.6 46.0 56.4 67.9 25.3
    Colon and rectum 54.8 58.0 66.6 73.8 19.0 55.3 59.0 68.5 75.8 20.5 54.2 56.8 64.1 70.7 16.5
    Liver 10.7 13.2 20.2 28.6 17.9 9.9 12.9 20.1 28.5 18.6 13.6 14.2 20.3 28.7 15.1
    Gallbladderb) 17.3 19.7 22.8 27.5 10.2 16.6 20.3 23.3 29.0 12.4 18.0 19.1 22.3 26.1 8.1
    Pancreas 9.4 7.6 8.0 8.7 -0.7 8.8 7.3 8.0 8.1 -0.7 10.1 8.1 8.1 9.5 -0.6
    Larynx 59.7 62.3 66.1 71.7 12.0 60.2 62.8 66.7 72.0 11.8 55.4 57.8 58.2 68.1 12.7
    Lung 11.3 12.7 16.2 20.7 9.4 10.4 11.6 15.0 18.3 7.9 14.2 16.2 19.7 26.8 12.6
    Breast 77.9 83.2 88.5 91.3 13.4 75.1 85.6 87.0 88.7 13.6 78.0 83.2 88.5 91.3 13.3
    Cervix uteri 77.5 80.0 81.3 80.1 2.6 - - - - - 77.5 80.0 81.3 80.1 2.6
    Corpus uteri 81.5 81.8 84.6 86.5 5.0 - - - - - 81.5 81.8 84.6 86.5 5.0
    Ovary 58.7 58.9 61.4 61.6 2.9 - - - - - 58.7 58.9 61.4 61.6 2.9
    Prostate 55.9 67.2 80.1 92.0 36.1 55.9 67.2 80.1 92.0 36.1 - - - - -
    Testis 85.4 90.4 90.6 93.2 7.8 85.4 90.4 90.6 93.2 7.8 - - - - -
    Kidney 62.0 66.1 73.3 78.8 16.8 60.8 64.4 72.8 78.4 17.6 64.5 69.7 74.5 79.5 15.0
    Bladder 69.1 73.1 75.5 75.4 6.3 70.0 74.8 77.3 77.4 7.4 65.5 66.3 68.5 67.0 1.5
    Brain and CNS 38.5 39.0 40.6 41.4 2.9 37.2 37.5 40.0 39.3 2.1 40.2 40.7 41.4 43.9 3.7
    Thyroid 94.2 94.9 98.3 100.0 5.8 87.2 89.5 95.8 100.1 12.9 95.4 95.9 98.7 99.9 4.5
    Hodgkin lymphoma 68.0 71.2 76.7 81.1 13.1 67.6 68.1 74.7 81.1 13.5 68.6 77.4 80.6 81.2 12.6
    Non-Hodgkin lymphoma 46.6 50.8 59.9 65.8 19.2 45.3 48.9 58.0 63.9 18.6 48.7 53.5 62.3 68.2 19.5
    Multiple myeloma 22.1 19.8 29.3 34.6 12.5 21.1 17.8 29.6 34.6 13.5 23.3 22.1 28.9 34.7 11.4
    Leukemia 26.5 33.3 41.8 48.0 21.5 26.2 32.3 41.6 47.3 21.1 26.8 34.6 42.0 48.7 21.9
    Other and ill-defined 42.1 45.9 55.8 66.3 24.2 37.4 42.4 52.1 62.4 25.0 47.4 50.0 59.8 70.3 22.9
    Site/Type Crude prevalence rate per 100,000a) Age-standardized prevalence rate per 100,000b)


    Both Male Female Both Male Female
    All sites 2,189.6 1,959.6 2,420.1 1,514.1 1,488.7 1,618.5
    Lip, oral cavity, and pharynx 31.0 41.9 20.0 21.7 31.4 13.4
    Esophagus 13.6 24.5 2.6 9.1 18.6 1.5
    Stomach 377.1 500.5 253.6 252.7 372.7 154.9
    Colon and rectum 308.9 367.7 250.0 206.3 276.4 150.7
    Liver 95.2 142.3 48.0 66.2 105.6 31.0
    Gallbladderc) 27.0 27.5 26.5 17.7 20.8 15.4
    Pancreas 12.7 14.0 11.5 8.6 10.6 7.0
    Larynx 16.2 30.5 2.0 10.9 23.2 1.2
    Lung 97.4 127.0 67.7 65.1 96.2 41.3
    Breast 234.8 2.1 468.0 161.1 1.6 316.3
    Cervix uteri 82.0 - 164.1 55.8 - 108.4
    Corpus uteri 27.1 - 54.2 18.9 - 37.1
    Ovary 25.8 - 51.6 18.9 - 37.4
    Prostate 84.1 168.1 - 53.0 129.0 -
    Testis 3.9 7.9 - 3.6 7.1 -
    Kidney 46.0 62.0 30.1 32.5 46.4 20.3
    Bladder 47.5 77.2 17.7 30.6 58.7 9.6
    Brain and CNS 16.0 16.6 15.4 14.2 15.1 13.3
    Thyroid 429.4 132.0 727.4 304.2 94.7 512.0
    Hodgkin lymphoma 3.6 4.6 2.6 3.1 3.9 2.3
    Non-Hodgkin lymphoma 47.1 51.2 43.1 35.3 40.8 30.6
    Multiple myeloma 6.8 7.3 6.3 4.7 5.5 4.0
    Leukemia 27.3 30.0 24.6 26.5 29.4 23.6
    Other and ill-defined 129.0 124.7 133.2 93.3 100.9 87.2
    Table 1 2011 Cancer incidence, prevalence, and deaths by sex in Korea

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2012. These are patients who were diagnosed between January 1, 1999 and December 31, 2011 and who were alive on January 1, 2012. Multiple primary cancer cases were counted multiple times,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 2 Crude and age-standardized cancer incidence rates by sex in Korea, 2011

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 3 The top 10 leading causes of death in Korea for 2011

    Source: Mortality data, 2011, Statistics Korea [1].

    Age-adjusted using the world standard population.

    Table 4 Crude and age-standardized cancer mortality rates by sex in Korea, 2011

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 5 Trends in cancer incidence rates for both sexes from 1999 to 2011 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p<0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 6 Trends in cancer incidence rates in males from 1999 to 2011 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p<0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 7 Trends in cancer incidence rates in females from 1999 to 2011 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p<0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 8 The five major sites of cancer incidence by age group and sex for 2011 in Korea

    CNS, central nervous system.

    Table 9 Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2011 in Korea

    CNS, central nervous system.

    Percentage change in 5-year relative survival from 1993 to 1995 and 2007 to 2011,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 10 Crude and age-standardized rates of cancer prevalence by sex on January 1, 2012 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2011 and who were alive on January 1, 2012. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP